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Executive Summary 
 
 
 
 
 
The arrival of cholinesterase inhibitors and guidance from the National Institute for 
Clinical Excellence (NICE) about use of these drugs has led to a rapid growth in memory 
clinics and other services designed to deliver them. However, little work has been done 
on the essential attributes of such services. This report takes an in depth look at two 
contrasting services in an attempt to elucidate some of the key issues. The research on 
which it is based involved a detailed comparison of the two services from a variety of 
viewpoints: 
 Service users, those who care for them and local Alzheimer’s Society branches 
 General Practitioners referring to the services 
 Clinical service providers 
 Those responsible for steering and developing services. 
It also explored the financial costs of the two service models and their ability to deliver 
compliance with the NICE guidance. 
 
The project examined the Wakefield Memory Clinic (MC) and the Huddersfield Memory 
Monitoring Service (MMS), two distinct services for people with dementia within South 
West Yorkshire Mental Health NHS Trust.  The research objectives were as follows: 
 
1. To evaluate service user, carer, referrer and staff satisfaction with the two services. 
2. To examine compliance with the National Institute of Clinical Excellence guidelines 
in the two services. 
3. To examine the process for patients who were not selected for treatment or for whom 
treatment was discontinued. 
4. To compare the direct costs of the two models. 
 
In order to ground our evaluation in the experience of service users and carers we began 
the study with detailed interviews with users and carers from both services. We also 
conducted interviews with local Alzheimer’s Society staff and conducted focus groups 
with staff. Based on a qualitative analysis of these interviews and groups, we constructed 
a questionnaire that was sent to larger numbers of patients, carers and referrers. To 
examine compliance with NICE guidance we conducted an audit of notes from both 
services. The cost data was based on the audit data and our analysis of the two service 
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models. Because of recruitment problems, we were unable to examine the experience of 
patients who were not selected for treatment. 
 
Satisfaction with the effectiveness of drug treatments was high in both services. Though 
users, carers and referrers were generally well satisfied with both services, higher levels 
of satisfaction with the service were recorded amongst users of the MMS.  This related to 
a number of issues: 
 
 People preferred being seen in their own homes 
 They enjoyed having a single worker (nurse) to whom they mostly related 
 They experienced better links between the service and the local Alzheimer’s 
Society branch, leading to better availability of information 
 They did not like the within-clinic waits at the Wakefield clinic. 
 
In both services, users and carers were reasonably well satisfied with general waiting 
times though providers were concerned that demand could outstrip supply, leading to 
increased waiting times. Service users and carers thought both services could have 
provided more information and links to other services. Staff were often concerned about 
the same issues as service users and carers. 
 
Compliance with NICE guidance on the use of cholinesterase inhibitors was high in both 
services.  The MC used a more comprehensive battery of cognitive, behavioural and 
other instruments, providing more robust diagnostic and monitoring data. The MMS 
utilised a smaller range of testing, reflecting the service’s priority in monitoring drug 
treatments amongst patients solely with Alzheimer’s disease.  Compliance with local 
standards was high. 
 
Financial analysis showed substantially lower costs for the Huddersfield (MMS) model. 
 
Both services were providing high quality and valued services to patients and their carers. 
The more personalised and community focused MMS was generally preferred and less 
costly. However, it did not provide such a robust and wide range of monitoring data. Both 
services could have been improved by the provision of more information and by better 
links into other aspects of social and psychological support services.  
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1 
Introduction and Literature Review 
                                                                                                    
 
 
1.1 Introduction 
 
Dementia is a devastating disease that affects a significant proportion of people, mostly 
over the age of 65 years. Services for old people with dementia have developed in the UK 
and around the world over the last twenty to thirty years or so, usually as part of specialist 
old age psychiatry services (Wattis, Wattis and Arie 1981). Services for the smaller 
number of younger people with dementia have developed more recently. In the last five 
to ten years services have been revolutionised by the launch of drugs for the treatment of 
Alzheimer’s disease, the commonest form of dementia. In the UK, this has resulted in a 
proliferation of Memory Clinics and similar services to facilitate early diagnosis and 
treatment of Alzheimer’s disease. The production of guidance from the National Institute 
for Clinical Excellence (NICE) has encouraged and shaped these developments. This 
report details a study comparing two services, one a “conventional” Memory Clinic and 
the other a nurse-led community-based service. The study involved interviews with 
patients, carers and staff, a questionnaire survey of a wider group of patients, carers and 
general practitioners, an audit of compliance with NICE guidance and an analysis of the 
direct costs of the two services. This chapter gives the background to the study and 
subsequent chapters deal with methodology, the different phases of the study and the 
conclusions to be drawn. 
 
1.2 Dementia and Alzheimer’s disease 
 
Dementia is a chronic, progressive organic mental disorder characterised by impairment 
of memory, thinking, orientation, comprehension, calculation, learning, language and 
judgment. Alzheimer’s disease is the commonest cause of dementia involving a subtle 
onset and slow deterioration, leading to difficulties in recognition and diagnosis 
(Askham, 1995). 
 
The Mini Mental State Examination (MMSE) (Folstein, Folstein & McHugh 1975) helps 
identify dementia and has been used to grade the severity of Alzheimer’s in accordance 
with the score achieved by the patient as detailed in table 1.1 
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Table 1.1 Stages of Alzheimer’s Disease 
 
STAGE OF 
ALZHEIMER’S 
MMSE  
SCORE 
DESCRIPTION 
Mild 21-30 The patient has temporary memory loss; they forget how to do 
familiar tasks and may be unable to remember familiar names or 
words. 
Moderate 11-20 The patient is more disorientated and may also become 
paranoid/delusional. Significant life episodes may be forgotten 
and there may be increased difficulty in recognising close 
relatives. Help is needed with personal hygiene and care. 
Severe 0-10 The patient has great difficulty in using appropriate verbal 
communication; they may have trouble feeding due to difficulties 
with swallowing. Twenty-four hour care is needed and 
increasingly there will be periods of bed confinement. The patient 
is also more open to secondary illnesses. 
 
1.3 Epidemiology 
 
In 1996, an estimated 750,000 people within the United Kingdom had some form of 
dementia. This was forecast to rise to 840,000 by 2010 (Alzheimer’s Society 2003).   
Dementia of Alzheimer Type (DAT) accounts for approximately 55% of all cases of 
dementia (Alzheimer’s Society 2004). In the UK in 1996, approximately 413,000 people 
had Alzheimer’s disease. This is set to rise to around 462,000 by 2010. Dementia was 
estimated by to cost the United Kingdom £6.1bn a year (at 1998-9 prices), with £3.3bn of 
this as direct spending by health and social services (O’Brien & Ballard 2001). 
 
1.4 Impact of cholinesterase inhibitors 
 
Acetylcholine is a neuronal transmitter, important in memory function and reduced in 
Alzheimer’s disease. It is broken down by cholinesterase enzymes. Cholinesterase 
inhibiting drugs, including donepezil, rivastigmine and galantamine are used for mild to 
moderate Alzheimer’s disease. They effectively amplify the action of the acetylcholine 
produced and released in the brains of people with Alzheimer’s disease, thereby reducing 
symptoms (Cameron et al 2000, NICE 2001, Lindesay et al 2002). 
 
The advent of cholinesterase inhibiting drugs has added impetus to the development of 
memory clinics and other services, specifically designed to facilitate early diagnosis of 
Alzheimer’s disease and delivery of theses drugs.  
 
1.5 National Institute of Clinical Excellence (NICE) guidance 
 
NICE provides the public and practitioners with authoritative, robust and reliable 
guidance on current best practice. In January 2001 NICE published guidance on the use 
of donepezil, rivastigmine and galantamine for the treatment of mild to moderate 
Alzheimer’s disease. Guidance incorporated the following recommendations: 
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• A diagnosis of Alzheimer’s disease must be made in a specialist clinic, which also 
investigates cognitive, global and behavioural functioning, activities of daily 
living and probable patient treatment concordance. 
• Specialists should initially prescribe treatment but general practitioners using a 
shared care protocol can continue treatment. 
• Prior to treatment commencing, and throughout the course of treatment, the 
carer’s views of the patient’s condition should be sought. 
• Once the patient’s maintenance dose has been determined, they should then be 
assessed 2 to 4 months later. Treatment should be continued if the patient’s 
MMSE score remains the same or improves and if the patient shows improvement 
on other measures, for instance on behavioural and functional assessments. 
• The patient should then have an assessment every six months with drug treatment 
continued only if their MMSE score remains higher than 12 and if the patient 
shows improvement or stability on other measures, for instance, on behavioural 
and functional assessments.   
 
1.6 Memory clinics 
 
The introduction of National Institute for Clinical Excellence (NICE) guidance has 
influenced the development of memory clinics in the UK, with fifty-eight active clinics 
operating at the last recorded count (Lindesay et al 2002). Van Hout et al (2001) 
identified the main objectives of memory clinics as to: ‘provide an ambulatory 
diagnostic, treatment and advice service for people with memory impairment and to act 
as a focus of research into dementia.’  However, the scope and functions of memory 
clinics vary widely, from those mainly concerned with research to those established more 
recently focusing on early diagnosis and treatment. Clinics are often multidisciplinary 
with teams including psychiatrists, psychologists, geriatricians, occupational therapists 
and mental health nurses (Wright & Lindesay 1995, Lindesay et al 2002).   While there 
are a variety of service models including community based care (Psychologists’ Special 
Interest Group in Elderly People 1998), most clinics are based upon institutional modes 
of care (Downs 2000).  This represents a shift away from traditional community oriented 
old age psychiatric services (Wattis et al 1999).   The memory clinic was listed in the 
recent National Service Framework for Older People (DoH 2001) as an essential 
component of services but as yet there is no general model within the NHS for the 
structure, function and clinical remit of a memory clinic.  (Wright & Lindesay 1995, 
Lindesay et al 2002). 
 
An audit of 93 patients over a three-month period in routine clinical practice found that 
47% of patients showed an improvement when treated with donepezil, but that treatment 
guidelines were not well followed (Cameron et al, 2000). The report argued for specialist 
services to improve compliance with guidelines. Memory clinics also probably help in 
early detection with patients being seen at earlier stages of the dementing process. (Luce 
et al, 2001). Moniz-Cook & Woods (1997) recognised psychosocial support for both 
patients and carers as a function of memory clinics and Lindesay et al (2002) showed that 
over half of the clinics they sampled provided some psychosocial support as well as 
delivering and monitoring medication.  
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Recently, work has been conducted on the role and impact of memory clinics in 
supporting carers, reflecting wider recent concerns about the health and wellbeing of 
carers (Moniz-Cook & Woods 1997, Murray & Livingston 1998, Logiudice et al 1999, 
Van Hout et al 2001, Vernooij-Dassen et al 2003). One study in the Netherlands 
demonstrated that memory clinics were more likely to communicate information on 
diagnosis to patients and carers when compared to traditional old age psychiatric 
services.  Outside memory clinics diagnoses were more commonly withheld from 
patients, largely rendering them voiceless in the doctor-patient-carer triad. (Haug 1994)  
Van Hout et al (2001) also demonstrated that patients and carers rated clinics positively 
in terms of the information provided to them on diagnosis and treatment.  A randomized 
clinical trial (Logiudice et al, 1999), showed memory clinics to have a positive impact on 
the quality of life of carers, particularly in the area of providing carers with support 
networks. Vernooij-Dassen et al (2003) recognized the need to consider the psychosocial 
impact of the diagnosis on patients. 
 
1.7 Alternative service models 
 
While memory clinics are becoming increasingly common, varieties of other services 
exist and contribute to management and care of people with dementia. In the UK, 
Psychiatric Services for Older People, traditionally community-focused, have always 
considered dementia in this age group within their remit (Wattis, Wattis and Arie, 1981). 
Keady & Adams (2001) in their examination of the roles of Community Mental Health 
Nurses (CMHN’s) found a paucity of evaluative work on nursing in dementia care. They 
found that Community Mental Health Nurses did not routinely differentiate subtypes of 
dementia though earlier work had demonstrated that nurses could effectively diagnose 
different types of early dementia using structured methods (Seymour et al 1994). 
Community oriented approaches to the treatment of dementia have been shown to 
provide particular benefit to patients and carers with respect to psychosocial support 
(Keady & Adams 2001, Woods et al 2003).   
 
1.8 The current study 
 
This study was a detailed comparative evaluation of two service models:  
1) The nurse led and community focused Memory Monitoring Service (MMS), and  
2) The hospital-based memory clinic (MC).   
 
Service models are shown in Fig 1.1.  We aimed to compare the two models in respect of 
the following variables: 
 
 Stakeholder satisfaction,  
 Compliance with NICE guidance and  
 Other benefits and costs.  
 
The methods used combine qualitative and quantitative measures of satisfaction with an 
audit of compliance with NICE guidance and of costs. The study aimed to give patients 
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and carers a voice in how services should develop and, by highlighting what works best, 
to facilitate innovation and the development of humane, effective and efficient services. 
 
Wakefield Memory Clinic  Huddersfield Memory 
Monitoring Service 
 
5th Visit 
Subsequent home visits at 6 
monthly intervals 
Efficacy assessment 
4th Visit  
Home 
4 months after baseline 
MMSE, BADL etc. 
3rd Visit   
Telephone call 
1 month after baseline. 
Side effects check.  Dose 
titration 
2nd Visit 
Out patient Department 
Baseline Diagnostic Visit 
Full baseline assessment 
And home visit shortly 
afterwards 
1st Visit 
 Home 
Memory monitoring nurse 
Prelim history & tests. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3rd Visit   
Contact by phone or visit 1 
month after commencing 
treatment, with further 6 
weekly dose titration 
2nd Visit   
Clinic 
Baseline Diagnostic visit 
Full baseline assessment 
(more prolonged and 
rigorous than the MMS) 
1st Visit 
 Home  
Memory Clinic Nurse   
Prelim history & tests. 
 
 
 
 
 
 
 
 
 
 
 
 
4th Visit   
Clinic 
3 month monitoring visit 
SMMSE, B-ADL etc. 
5th Visit 
Subsequent clinic visits at 6 
monthly intervals 
Efficacy assessment 
Fig 1.1 Outline of Memory clinic/Memory Monitoring Service models. 
These models are approximations. The Wakefield Memory Clinic introduced a preliminary 
nurse visit part way through the study and the Huddersfield MMS included a baseline 
assessment visit after the short diagnostic attendance at clinic. Neither service achieved 
complete ‘fidelity’ to their model. The MMS protocol allowed for the nurses to report six-
month assessments to the Consultant. Sometimes this was done face to face, sometimes by 
written message. Patients were not routinely reviewed in clinic like the Memory clinic service. 
If they required complex care packages, these were arranged in the usual way, by or through 
the Community Mental Health Teams and/or the Social Services department. The memory 
clinic was not any different in this respect. Both services were complimentary to existing 
services rather than aiming to be ‘one stop shops’ for all the needs of people with dementia 
and their carers. 
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2 
Research Methods 
 
 
 
We used different methods for each part of the study. These are outlined below. The 
study was conducted in accordance with the Declaration of Helsinki. The protocol was 
peer reviewed and approved by the ethics committee of the School of Human & Health 
Sciences at the University of Huddersfield. The Research Approval group of the South 
West Yorkshire Mental Health NHS Trust and the Wakefield Local Research Ethics 
Committee (LREC) also approved the study. Necessary variations in the protocol were 
approved by the LREC. Further details of how we managed ethical considerations around 
interviews, focus groups, potential distress, and withdrawal from the study and 
confidentiality are available on the web version. All data was anonymous at the point of 
collection and stored and disposed of appropriately, in accordance with the Data 
Protection Act (1998). 
 
2.1 Objective 1: Satisfaction with the service 
 
This was split into two phases. In the first we used qualitative interviews to explore user, 
carer and staff views. In the second we developed questionnaires based on the qualitative 
data and used them in a wider sample to enable a more robust comparison of the services. 
We tried to include patients, carers, referrers (GP and Consultant) and staff from both 
services in the first phase and patients, carers and GPs in the second.  
 
2.1.1 Phase 1 
 
Patients and carers 
For each service we identified a link nurse to help recruit possible participants and 
prevent selection bias by the researchers. A variation in the protocol allowed 
representatives of the Wakefield and Huddersfield branches of Alzheimer’s Society to 
help with recruitment.  Eligible service users (patients and carers) were identified, given 
an information sheet and personally invited to participate. 
  
We asked those who were willing to participate to send confirmation in writing to the 
research office. One of the researchers telephoned potential participants and reminded 
them that involvement was voluntary and that they could withdraw at any stage. The 
researcher went through details of the study again, answered any questions and set a 
mutually convenient date, time and place for interview. A written information sheet was 
provided. 
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Before the interview, the researcher provided any further information required. All 
consent forms were signed in the presence of a researcher or a member of NHS staff. We 
assessed competence to consent on the basis of the participant being able to understand 
the outline of the study and their potential role in it. They needed to be able to remember 
the information for long enough to weigh it in the balance and come to a decision. 
Subjects were asked to agree to their main carer also being approached.   We obtained 
informed consent from carers according to the same principles.  30 patients in 
Huddersfield and 30 patients in Wakefield were given information and invited to 
participate. Five patients and their carers from each service agreed to participate.  
 
We conducted interviews at the homes of the patients. Two members of the research team 
conducted the interviews. Interview schedules were structured to explore the following 
issues: 
 
• Satisfaction or lack of satisfaction with the services. 
• Timeliness. 
• Preferences for being seen at home or in clinic. 
• Satisfaction with information provided. 
• Communication. 
• Any other aspects raised by participants. 
 
With permission, we recorded interviews. Each lasted approximately one hour. We give a 
full qualitative analysis of these interviews in chapter 3. 
 
Referring GPs and Consultants 
We approached referring GP’s and consultants and asked them to take part in an 
interview.  The lead consultants of the two services signed invitations for interview in the 
hope this would improve recruitment. Unfortunately, none of the referring GP’s and 
Consultants (other than the two consultants involved in the research) agreed to be 
interviewed, in some cases citing lack of time as a reason for refusal. We managed to 
collect GP data later, through the questionnaire (see below). 
 
Memory service staff  
We asked the link nurses to list the staff and others involved in steering and providing 
their services. We then wrote to these people inviting them to a focus group. We included 
an information sheet and consent form with the invitation. Before each focus group, the 
researcher explained the participant’s rights and the ethics of the study, and obtained 
written consent from participants.  
 
We asked 10 people from Wakefield and 10 from Huddersfield to participate. Six from 
Wakefield and four from Huddersfield agreed. Two members of the research team 
conducted focus groups with the staff/steering groups of each service. We explored the 
perceived advantages, disadvantages, strengths and weaknesses of the services and 
examined satisfaction with service models. 
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We seated participants in a circle to facilitate interaction. We standardised group 
introduction including a description of the study, its purpose, data handling and 
dissemination. We requested permission to tape record the discussion and to take notes. 
The focus groups each lasted approximately one hour. We include a full analysis of these 
interviews in chapter 5. 
 
Alzheimer’s society representatives 
We conducted two further interviews with representatives of the Alzheimer’s Society 
recruited through their involvement in the research steering group. We explored themes 
pertinent to services in their locality that had arisen during the patient and carer 
interviews. Before each interview, the researcher explained the participant’s rights and 
the ethics of the study and obtained informed written consent.  We interviewed one 
representative from Wakefield Alzheimer’s Society and one from Huddersfield 
Alzheimer’s Society at the branch offices.  We questioned representatives regarding their 
involvement with the Memory Monitoring Service/Memory Clinic, and with patients 
using these services and their carers.  
 
2.1.2 Phase 2 
 
On the basis of analysis of these interviews and groups, we constructed brief patient, 
carer and doctor questionnaires.  We piloted these on five patients and their carers from 
each service, and then sent them to a sample of patients and carers from each service, 
their referring consultants and general practitioners.  The questionnaires explored 
satisfaction with different aspects of the services. 
 
Patient and carers 
Link professionals provided the researchers with the names and addresses of patients 
believed to be actively receiving treatment within the service. We sent all patients and 
their carers study information, a questionnaire and audit consent form. A total of 415 
questionnaire packs were sent to patients using the services, 225 in Huddersfield and 190 
in Wakefield. Each contained information sheets a patient and carer questionnaire and pre 
paid envelopes to encourage response.  We sent a covering letter with the questionnaires, 
highlighting the anonymity and confidentiality of names, addresses and data and making 
it clear that participation was voluntary.  We invited patients to contact the research 
office in the event of them requiring assistance to complete the questionnaire. We also 
alerted the link professionals and the representatives of the Alzheimer’s Society prior to 
questionnaires being sent out, to enable them to deal with any queries that came their 
way. We received 46 patient and carer questionnaires from the MMS and 15 patient and 
carer questionnaires from the MC. 
 
We standardised questionnaires between the Huddersfield and Wakefield services and 
between patients and their carers to enable cross comparison but tailored the wording of 
questions to reflect each service. We also included a consent form requesting individual 
patients to consent to taking part in an audit of patients’ medical records for phase 3 of 
this research project.  
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Referring GPs  
We sent questionnaires to referring GP’s. We recruited GPs for Huddersfield from a list 
provided by the MMS. The MC could not provide a list of referring GPs in Wakefield 
and to gain an appropriately sized sample, we sent questionnaires to all GP practices 
within the MC catchment area. We sent 82 questionnaire packs to Huddersfield 
practitioners and 114 to Wakefield practices. Each contained a questionnaire, an 
information sheet detailing the study, and pre paid envelopes. We sent a covering letter, 
detailing the project and its objectives. Huddersfield GPs returned 17 (21%) 
questionnaires and Wakefield GPs. 21 (18%). The GP questionnaire was brief to 
encourage response. It also requested descriptive information from GP’s, allowing for 
some qualitative evaluation of responses. Questionnaires were designed with the 
assistance of medical and academic professionals with relevant expertise.  
 
2.2 Objective 2: Compliance with NICE guidance 
 
We explored compliance by conducting an audit of case notes from each service. We 
sought informed consent to examine the medical records of service users during the 
questionnaire stage. Most respondents gave consent. Case notes were audited on hospital 
premises by or in the presence of professional staff. The poor response rates meant that 
numbers were small. Because of this, at the analysis stage, we augmented the data with 
anonymous data from clinical audit. A total of 67 patient case notes were audited from 
the MC and a total of 78 case notes were audited from the MMS. 
 
2.3 Objective 3: Satisfaction of those not receiving treatment 
 
Originally, we planned to approach five patients from each service who had not been able 
to start treatment or for whom treatment had been discontinued. We wanted to interview 
them and their main carers to gain their views and experiences about not receiving 
treatment. We identified patients with the assistance of the link professionals.  
Unfortunately, nobody consented to take part in an interview. Link professionals 
attributed the lack of volunteers to: a) a relatively small population for whom treatment 
was not started or discontinued; and b) severity of dementia, other illness or death in this 
group.  Another possible reason was disaffection with a service that had either refused or 
terminated treatment but we were not able to explore this.  Consequently, we had to 
abandon this stage of the research. 
 
2.4 Objective 4: Cost analysis 
 
We drew up a schedule summarising the frequency of and types of contacts in the two 
services. We used the clinical audit to determine routes of entry into the service, and to 
record the range and frequencies of diagnostic tests conducted. We used this information 
to determine the financial costs of the services. We collated other direct costs of the 
different models of service, for example transport. The schedule was applied to all 
patients from each service to enable a comparison of costs-per-case on a like-for-like 
basis.  As a cross check we used financial information collected from link professionals 
as part of a preliminary report written in May 2003. 
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Costing model 
We developed a costing model to analyse costs per case of each service. All costs were 
entered into this model and subjected to a sensitivity analysis applying different scenarios 
identified in the audit phase of the study. 
 
 Total number  
of patients  
per year  
 
 
    X    = 
 
Intervention cost 
per patient 
Total 
intervention cost 
     
 
X   =    
 
 
 
No. patients 
fluctuating/increa
sing  
Annual 
intervention 
cost 
Service  
Implications
Fig 2.1 Annual cost model for memory service resource implication 
 
Data analysis 
Identification codes were used to protect anonymity and all tapes were destroyed in 
compliance with the 1998 Data Protection Act. We analysed quantitative data using SPSS 
(the Statistical Programme for Social Sciences) version 11. We transcribed all qualitative 
data verbatim and subjected it to template analysis (Crabtree and Miller, 1992).  
 
In template analysis, the researcher develops a number of codes (a template), highlighting 
themes and constructs found within the text. The template is modified as the researcher 
repeatedly reads, codes, and provides interpretation to relevant text Template analysis is 
similar to ‘content analysis’ (Weber 1985) and ‘grounded theory’ (Glaser and Strauss, 
1967). However, in content analysis, all codes are made prior to analysis of the text, 
which is carried out statistically. In grounded theory there are no preconceived ideas 
about the codes to be used. Template analysis lies somewhere between these approaches 
and is more flexible (King 1998). 
 
One researcher developed a template for patient and carer transcripts, starting by 
reviewing the text from a pair of transcripts, adding annotation and simple, descriptive, 
coding using the interview schedule to predefine categories. The researcher then returned 
to the text and provided more interpretation by clustering codes together and ascribing 
meaning to each group. This began a process of hierarchical coding, with more general 
codes leading to more defined and specific ones. All the other transcripts were then 
coded, using the initial templates which were revised as a result of observing the other 
transcripts. Existing classifications were adjusted, further dimensions were added to 
codes, areas were deleted, and new constructs were developed. 
 
A second template was developed for the analysis of the Alzheimer’s Society 
representative interviews, initially using the text of one transcript and subsequently 
developing and revising the template as detailed above. A third template was developed 
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in a similar way for the focus group data. The final templates were indexed and provide a 
tight and clear organisation of the data and a well-ordered means for analysis.  
 
2.5 Establishing research trustworthiness/ reliability and 
validity 
 
The structure and findings of the study are reported (with more detail available on the 
web version). The theoretical background, the general methodological framework and 
method of analysis involving peer review are specified and appropriate to the research 
subject. Quantitative data were analysed using standard methods with appropriate 
corrections. Qualitative data were evaluated by comparing the responses of all 
participants. As all participants mentioned similar issues, there was confidence in the 
credibility of themes. A second researcher provided a check on the plausibility of all 
categories and the consistency of subsequent coding for each template. There was usually 
consensus on common themes emerging from the data but some disparity as to the best 
way to capture these within categories. Through discussion of the rationale underpinning 
each category and re-examination of the data, agreement was reached. Outstanding 
discrepancies in themes were resolved by modifying the boundaries of themes or creating 
new themes. The study structure is not limited to the environment and sample used; the 
same procedures could be used to investigate other phenomena. The steps taken in 
carrying out the study are clear, systematic, efficiently documented and include 
safeguards against bias.  
 
2.6 Study organisational structure 
 
We established a research steering group to support and monitor the project. This 
included representatives from Alzheimer’s society and university based researchers with 
expertise in qualitative and quantitative methods and research into old age psychiatry. 
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3 
Objective 1: Patient and Carer Interview Findings 
 
 
 
 
3.1 Introduction 
 
Ten dementia patients and their carers were interviewed where possible separately. Of the 
ten carers interviewed, four were married to the patient and two were long-term partners. 
Four of the patients within the MMS sample were male. Four of the MC patients were 
female. MMSE scores for MMS patients ranged from 22-30 and for MC patients from 12-26. 
Five main themes and a range of related themes were identified (Table 3.1). 
 
Table 3.1 Summarised patient and carer interview coding template. 
FIRST LEVEL THEME LOWER LEVEL THEMES 
1. Perceptions of dementia 1.1 Causal attributions of dementia 
1.2 Events leading to diagnosis 
2. Treatment location  2.1 The community based model 
2.2 The hospital based model 
2.3 Preference for treatment location 
3. Timeliness 3.1 Satisfaction with waiting times to access the service 
3.2 Clinic waiting times 
4. Satisfaction with the service  4.1 Drug treatment 
4.2 Assessment and diagnosis 
4.3 Personal qualities of staff 
4.4 Individualised service 
5. Information provision 5.1 Range of information provided 
5.2 Satisfaction with information provided 
5.3 Communication style 
5.4 Satisfaction with external information sources. 
 
3.2 Perceptions of dementia 
 
The perceptions participants held of dementia shaped their behaviour and reasoning. Two 
main sub-themes were identified: causal attributions of dementia and events leading to 
diagnosis.  
 
Causal attributions of dementia 
Each participant discussed their own perceptions about the origins of dementia. Most 
thought dementia to be a natural part of the ageing process. Dementia was initially 
understood as a heightened sense of ‘absent mindedness’, rather than as a clinical 
condition. Despite being given information about the disease, some participants still had 
their own ideas about possible causes, actively searching for evidence to support these 
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ideas. Dementia was seen as due to old age together with other factors, including level of 
intelligence, previous career, and in one case, having been anaesthetised:  
 
‘My wife had an operation and ever since then, her memory has not been 
so good … I believe it is the anaesthetic… I said to the nurse…‘would 
you mind asking the consultant if it can be the anaesthetic what causes it’ 
and she said ‘well to be honest with you… it has already been put to the 
consultant and he says if the weakness is there it will bring it out’ …so do 
not ever have an anaesthetic if you can help it’ (MMS carer). 
 
Events leading to diagnosis 
Most dementia patients, with their carers, made incremental adjustments in their daily 
lives to cope with dementia as it progressed, often scaling down their expectations of 
quality of life. Patients and carers were aware of difficulties arising from memory loss, 
but fear and embarrassment discouraged a visit to the GP until a ‘crisis point’ where 
struggling with the difficulties led them to feel that medical advice or intervention was 
needed, for example: 
 
‘I realised it… four and a half years ago.  My husband could not 
remember eating his Christmas dinner.  There were a few incidents 
before that… But it would be about six o clock in the evening when he 
asked me what day it was, and of course it was Christmas day’ (MMS 
carer). 
 
And, 
 
‘Mainly it was the forgetfulness.  I mean I had a good brain before, I 
mean I were in the [] service for twenty-five years… and suddenly I 
started forgetting things.  I had to ask the wife time and time again for 
all sort of things… I got very frustrated to start with; I could not come to 
terms with it’ (MMS patient). 
 
Memory impairment was difficult to accept and adjust to for both patients and carers and 
some ignored the signs in the hope that they would improve or at least not get worse. 
 
3.3 Treatment location 
 
The major difference between the two services evaluated was that one was community 
based and the other hospital based. Participants made interesting comments with regard 
to this. These are summarised and addressed in three main themes; the community based 
model, the hospital based model and preference for treatment location. 
 
The community based model 
The community basis of the MMS was highly regarded by patients and carers. This was 
commonly viewed as the main advantage of the MMS. Participants highlighted the fact 
that they did not need to use public or other means of transport to regularly travel to a 
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clinic for appointments. While several participants retained mobility, several noted that 
since the onset of dementia, their mobility had been restricted. Several participants also 
noted a desire to avoid using public transport where possible. Being seen at home eased 
the burden felt by the carer, and avoided the anxiety and distress felt by patients in 
considering the practicalities of attending hospital. 
 
Whilst most MMS participants appreciated the need for an element of the service to be 
clinic based, for instance for medical scans to be conducted, all participants expressed a 
preference for the design of the MMS: ‘It has been damn handy and they have been 
damn good, well they have been good for me …You’re more comfortable in your 
own home than you are going waiting in a corridor’ (MMS Carer). Participants from 
each service said that hospital visits could cause increased anxiety for patients, 
exacerbating memory difficulties. No one noted lessened contact with consultants as 
being a particular criticism of the service. 
 
Increased anxiety felt by patients within clinic settings was attributed to a variety of 
causes; including the length of time waiting within clinics, difficulties in traveling to 
clinic, the physical environment of the clinic and general perceptions of hospital 
environments.  One MMS patient mentioned the anxiety associated with exposure to 
others with more severe dementia.  This could cause distress to patients and carers by 
showing what might be expected as the disease progressed.  Several carers, perhaps 
projecting their own feelings, attributed this distress to the patient.  Receiving help at 
homes removed the risk of this exposure: ‘I think if you went into the hospital you 
would be sat in a waiting room, you are going to see people far worse… that can be 
very distressing in itself’ (MMS carer). MMS carers particularly felt that being assessed 
at home allowed for a more accurate depiction of the patient’s cognitive decline:  
 
‘I think it is more friendly if its in your own home…and especially for my 
husband because he is in his own environment, and he will be more 
relaxed, whereas I think if you go to a clinic, you can all be very tensed 
up, and wondering what is happening with the people coming in white 
coats’ (MMS carer). 
 
MMS participants felt that receiving treatment at home enabled them to communicate 
more openly.  They felt more able to “be themselves” within the home environment: 
 
‘If you are in the hospital you are in a different place altogether, you are 
sitting on your own settee, with your own carpet and your own furniture 
all around you, you can be yourself… But in hospital, some change 
comes over you, and you simply are not the same, you are not as relaxed, 
tense, wondering what they are going to say next, what is going to 
happen next and so on’ (MC carer). 
 
Several carers noted that they did not feel as free to discuss pertinent issues within 
hospital environments, where their interpretations and previous experiences of hospital 
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settings constrained their ability to communicate freely and in a relaxed manner with the 
medical professionals. 
 
The hospital based model 
While most participants thought that treatment had benefited patients, two MC carers 
questioned whether the level of benefit achieved was worthwhile, given the perceived 
effort required in gaining the treatment: ‘I mean the treatment is limited, as you know, 
so it makes you wonder sometimes if you are going through a lot of hoops for no 
reason at all, if you understand my logic’ (MC Carer).  
 
One major cause of variation in levels of satisfaction with the MC was the particular 
pathway patients took within the clinic. Two distinct pathways were identified.  In one, 
patients were seen in a single appointment conducted by a nurse consultant.  Within these 
appointments, tests were conducted prior to a consultation and diagnosis with the same 
professional. Because the nurse consultant could provide a diagnostic opinion, a second 
appointment with a psychiatrist was not required.  Carers and patients on this pathway 
expressed high levels of satisfaction: ‘I like that man; (…) He makes me feel 
comfortable’ (MC Patient). These feelings of comfort were helped as patients in this 
pathway remained in regular contact with one member of the clinic staff. The alternative 
pathway involved two distinct appointments within the same visit; an initial appointment 
with a nurse where assessments were conducted, combined with an appointment with 
either a staff grade or consultant psychiatrist, in which diagnoses were made and 
treatment initiated.  Several participants expressed dissatisfaction with this system, 
largely based on the wait between appointments.  Appointments also regularly fell short 
of their allotted time-slot, further increasing the waiting time between the nurse and 
psychiatrist appointment.   
 
Another problem in the MC, raised by MC carers, was the need to travel to the nearby 
Pinderfields Hospital pharmacy to collect prescriptions. This was a particular problem for 
frail patients using the clinic, and was an inconvenience for carers, as it placed an extra 
task upon them.  One MC carer suggested that drugs could be distributed within the clinic 
itself, streamlining the system: ‘Well you would not want to push somebody in a 
wheelchair would you… why they cannot be distributed in the clinic I do not know’ 
(MC carer). However, since the data collection phase of this study the MC service has 
developed and carers no longer have to collect all prescriptions from the hospital 
pharmacy, as GP’s take over all prescribing after the initial dose titration. For MC 
participants, the issue of traveling to the clinic was also a concern.  Several lived a good 
distance from the clinic, resulting in patients having to endure long journeys.  While 
several relatively young carers stated that it was not a problem for them personally, they 
recognised that traveling to the clinic might cause problems for patients less mobile or 
without transport: 
 
‘I am fortunate in being younger; having a car and being able to 
travel… a lot of people struggle to get into Wakefield.  If I went on the 
bus I would have to change four times from here… or wait for an 
ambulance… so it can be a problem’ (MC carer). 
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Amongst patients and carers who were not able to drive themselves to clinic, most stated 
that they relied on friends and family for transport.  Several said they had been offered 
ambulance transport, but usually made other arrangements. While the ambulance was 
thought to be a necessary service for many individuals using the clinic, for most of the 
participants interviewed it was seen as a last resort.  
 
Preference for treatment location 
All participants were questioned regarding their preference for a clinic or community 
based model. All participants had received community-based assistance at some point 
and thus felt able to give some opinion, in all cases stating a preference for a community-
based service. The preference for a community service was most commonly based upon 
the issues of comfort and familiarity with the home environment. One MC carer stated 
that the patient felt anxious about visiting the memory clinic and described how the 
patient’s lack of familiarity with the clinic environment and staff, increased feelings of 
discomfort and anxiety: 
 
‘They go through the initial anxiety each time… which is not helpful… I 
have found with (patient)… if she is anxious… she will almost become 
like a headless chicken… the more anxious they get, the less able to deal 
with a situation they are.  That is my experience anyway… other people 
might find it different’. (MC carer). 
 
The feelings of anxiety resulting from attending a clinic were thought to impact upon the 
patient’s cognitive and functional abilities, maybe adversely affecting any assessment. 
Several carers noted that prior to clinic visits patients became nervous. Several MC 
patients stated that they thought they would be able to perform at a level more reflective 
of their true abilities if the tests were conducted at home. 
 
A community nurse who occupied a relatively new post in the MC had visited one patient 
and carer. The duties of this post included preliminary home visits to patients, when 
diagnostic testing was conducted, and where patients and carers were given information 
about the clinic.  Both were highly satisfied with the visit, and the assistance provided. 
They appreciated advice provided to them on how to adapt to memory problems: 
 
‘Carer: What happened was, we got a letter back from them, and they 
said that if we were willing, (memory clinic community nurse) would 
come, and he would give us an assessment here.  He came, and he was 
very good. He asked us to… 
Patient: Told me to get something like this (points to tear off calendar) 
tell me what day it was, something like that’ (MC patient and carer). 
 
The MC community nurse post was also judged effective in preparing individuals for 
clinic visits and in reducing apprehension experienced prior to clinic appointments.  The 
community-based element that has been added to the clinic-based service model has 
increased levels of stakeholder satisfaction. All MMS participants reported satisfaction 
with the service they received and would like the service to remain community based. 
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Patient and carer preference for care at home appeared to be influenced personal 
memories and local history.  For one MMS carer in particular, a general dislike of St 
Luke’s hospital in Huddersfield, where clinical appointments took place was a major 
reason for preferring a community-based service.  This dislike was based on personal 
memories of the hospital where both the carer’s parents had died and on the history of the 
hospital site. It had been a workhouse and a mental hospital where patients were taken 
prior to transfer to Storthes Hall, a local asylum closed years ago:  
 
‘I hate the place.  I absolutely hate Saint Luke’s, I dread it, I dread going 
because my mother died there and my father died there… and you see in 
my days it was the workhouse.  It was the local workhouse.  It was a 
stigma to be sent to Saint Luke’s’ (MMS carer). 
 
Other participants shared this dislike but did not feel it so strongly. The community-based 
design was felt by several carers to reduce the perceived stigma of dementia and mental 
illness by lessening exposure to sites associated with bad memories. 
 
3.4 Timeliness 
 
We asked questions about satisfaction with waiting times. Responses identified two main 
themes, waiting times to access services and waiting times within clinic. 
 
Waiting times to access services 
Few participants expressed any problems with an acknowledged waiting time of 
approximately 2-3 months between the GP/consultant referral and the contact with 
MMS/MC personnel. Most patients and carers had a generally favourable reaction: 
 
‘Carer: And he actually, you know we got a day and a time to go and see 
a nurse and a doctor, and so we did not seem to be waiting long at all… 
Patient: I know they have had complaints… I was sort of really 
surprised… 
Carer: They were really good’ (MC patient and carer). 
 
The experience of the waiting time for access to dementia treatments was judged in 
comparison with experiences of other NHS services: 
 
‘The one thing we do not agree with is, like he is waiting for a 
replacement knee… they said there was a long waiting list for that 
obviously… but you see he has got to wait between six and nine months 
before they can even consider him for a knee replacement… so we have 
no arguments at all with this memory service’ (MMS carer). 
 
The level of satisfaction was also related to the level of cognitive decline found in 
patients.  Most showed minor impairment, and were still able to perform many activities 
of daily living.  Because of this, carers did not generally feel a high level of urgency.  
Two carers were concerned about waiting times. For one MMS carer, this was based on 
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the stress experienced in caring for her husband and anxiety about progression of the 
illness. One MC carer was also concerned about illness progression. The patient had 
started treatment a number of years previously when waiting times were longer. All were 
satisfied with the regular six monthly nurse follow up. Some would have preferred more 
frequent visits.  
 
Waiting times within clinic  
As part of the MMS model, patients attended a single diagnostic clinic assessment.  Due 
to preferences amongst consultants operating in conjunction with the MMS, some 
patients also had clinic appointments as well as the regular visits from MMS nurses. 
Several were dissatisfied with the waiting time in clinic for their consultation.  One carer 
described waiting for two hours for a consultant appointment. 
 
For memory clinic participants, this anxiety was sometimes exacerbated by the length of 
time they had to wait to see a doctor and nurse separately: ‘So even after half an hour 
you have got half an hours wait if everything, if you have got an appointment that 
follows straight on.  But more often than not they do not follow on; you might follow 
on another hour after that’ (MC carer). Carers felt that this increased the amount of 
inconvenience they suffered. These problems were attributed to the organisation and 
management of appointments, rather than individual clinic staff.   
 
For patients allocated to the MC’s single appointment pathway, participants were highly 
satisfied with waiting times within clinic.  All patients acknowledged that a certain 
amount of waiting was expected and the waiting times within clinic were never 
unacceptable.  One carer congratulated the MC on promptness and flexibility:  
 
‘I do not think it was the last one, but maybe the one before, we were 
there early, we were in early and out… so, the other times, quarter of an 
hour to half an hour after the appointed time.  But that is not something 
I would worry about, with the hospitals as they are… and I certainly 
would not moan about being seen after time when we have been seen 
before time’ (MC carer). 
 
Most carers were flexible regarding waiting for clinic appointments, and forgave minor 
increases in waiting times. While patients and carers may and do complain amongst 
themselves, they appeared unlikely to make any formal complaints. One carer attributed 
this to having an innate respect for medical professionals. 
 
3.5 Satisfaction with the service 
 
All participants were satisfied with the service they received. This was most commonly 
based on benefit experienced from the anti-dementia medication. Four major themes were 
identified; the Drug treatment, assessment & diagnosis, the personal qualities of the staff 
and the perceived individualisation of treatment. 
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Drug treatment 
All patients were receiving anti-dementia medication. Patients and carers were highly 
satisfied with the benefits of drug treatment. MC carers were generally more aware of the 
limited benefit that treatment might have, and realised that major improvements in 
cognitive ability were unlikely.  Where benefits did occur, carers felt that the drugs had 
usually performed as well as could be expected based upon the knowledge given to them 
by staff in the memory clinic. Treatment, at the very least, stabilised overt memory loss: 
 
‘She seemed to me to get a lot worse very quickly, and I do not think she 
has got any worse.  I think, like he said, its going to hold it a bit, hold it a 
while…  I would not say she was any better no…  certainly over the last 
few months, while she has been on them, she has not deteriorated to my 
mind as quickly as she did before’ (MC carer). 
 
A few carers reported treatment had helped to stabilise the increasingly erratic behaviour 
exhibited by patients in the moderate stages of the disease.  
 
Carers of patients with milder levels of impairment noted improvements to memory 
recall, and to the patients’ general attitude. All carers stated that patients Mini Mental 
State Examination (MMSE) scores had stabilised or improved. In one MMS participant, 
an overall improvement of six points was seen: ‘When we started with this, they gave 
him a test out of thirty… the first test he did he was 23 out of 30.  The second test 
was 27, then it went up to 29 which they were thrilled with’ (MMS carer). Several 
carers thought the drug had lifted apparent depression / disinterest in the patient: 
 
‘My husband had stopped being interested in the garden for a start, the 
garden got on top of him and he lost all interest in it…well in this past 
twelve month his interest has picked up, he has redone the garden he has 
restyled the back rockery and he has started on the front rockery… 
periodically, flowers and that, he would forget to put the bulbs in and 
what-have-you, well now he remembers’ (MMS carer).   
 
Patients described how they felt medication had improved memory, general ability to 
cope with disease-related changes and well-being: 
   
‘In some respects my memory, it has improved…if I talk I can confuse 
myself a little bit, but when I am out… with all my friends, on a walk, we 
have a chat and I can remember more now…I mean I would like to store 
a little bit more but I mean…I am accepting it yes, It has not been, how 
can I put it, as devastating as I thought it would be because these drugs 
are helping me’ (MMS patient).
 
Assessment and diagnosis 
Most participants accepted that memory tests and other measures were needed to help 
diagnosis and assess progress. However, two MC carers raised issues about how they 
were separated from patients whilst assessments were performed.  They assumed that this 
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was to enable staff to measure memory without carer assistance but were concerned 
about the patients’ possible distress as a result of this separation.   
 
Amongst MC participants, the use of memory tests and other rating instruments were 
understood to be part of a formal and hierarchical system, based around the requirements 
of the service to provide a rapid service to many patients. They thought the main role of 
nursing staff was to administer memory tests.  Patients and carers felt that clinic 
appointments were solely based upon testing, diagnosis and treatment. Patients saw the 
MMSE as a formal test that they were required to pass. Several participants noted that 
they had asked memory clinic staff whether they had “passed” the test: ‘I do not know if 
I was that good at it.  I asked them if I passed…She did not actually say…’ (MC 
carer). Carers were concerned about whether a patient might become distressed during 
the test as a result of answering incorrectly, or of being unable to give an answer. 
 
One MC carer said that some rating instruments given to carers were hard to understand.  
This carer also challenged the numerical basis of many of the assessments, noting 
difficulties in comparing current answers with those given during previous assessments: 
 
‘It can be counterproductive because if you fill them in every three 
months you have forgotten the level you put last time so you are having a 
complete stab at it, you have forgotten.  You have not got a baseline to 
work from.  So your points can be all over the place.  You know.  Have 
things got worse; well what did I put last time.  1, 3, 4, 7, 12, whatever.  
Well I have put six, and last time I put 7, because you have not got a 
baseline to work from’ (MC carer). 
 
Personal qualities of staff 
The relationship between patients, caregivers and memory service personnel influenced 
the degree to which participants valued the service they received. All MMS participants 
were highly satisfied with the MMS nurses, highlighting their friendliness and 
informality. The same nurse routinely visited each patient and carer. Participants valued 
this continuity, especially in the earlier stages of the process.   They felt more able to ‘get 
to know’ the nurse visiting them, and more able to build trusting relationships with them.  
 
The relationships developed between MMS carers and nurses enabled carers to feel more 
confident in discussing difficult and sensitive issues. Participants felt that visits by the 
MMS nurses were informal, relaxed affairs in which patients and their carers were able to 
feel comfortable: ‘There is no officialdom or anything about them, they come in, they 
will sit and they will have a coffee and they will chat you know.  Which is what we 
like.  And they make you feel comfortable’ (MMS Carer). Several participants 
highlighted that the nurses offered them support as if they were friends, rather than 
medical professionals.  Some carers described the nurses as like family members: ‘The 
nurses that come, they are wonderful… they come in and they are more or less one 
of the family’. (MMS, carer). Carers did not identify any specific methods that the nurses 
used to monitor their physical and mental health but all felt that the nurses showed 
concern for their needs, and either provided or directed carers to sources of support and 
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assistance. MC participants developed less formal relations with the nurses and more 
formal relations with the doctors at the clinic. They felt more at ease with the nurses. 
 
Individualised service 
MMS carers felt that the service was individualised to meet the needs of patients and 
carers. Carers reported different levels of support and information provision, but overall 
more MMS than MC participants thought the service they used gave sufficient support. 
 
Participants stressed the ease of use of the MMS. They suffered little or no inconvenience 
from the nurse’s visits: ‘Everything that has had to be done has been done.  I cannot 
criticise them and with regard to the manner in which I have been treated I could 
not ask for better. No I could not really’ (MMS patient). Participants did not think that 
the friendly approach had resulted in any loss of medical rigour. This approach to service 
delivery was contrasted with participants’ previous experiences of other NHS services.   
 
3.6 Information provision 
 
Most interviews included discussions about information. Participants expressed a desire 
for more knowledge regarding the condition and help that might be available. We 
identified four main themes; range of information provided, satisfaction with information 
provided, communication style and satisfaction with external information sources. 
 
Range of information provided 
Several interesting contrasts were apparent. Most participants said that the MMS nurses 
gave little general information to participants.  Most information from the service 
appeared to be given verbally during appointments, with a paucity of written information. 
Several participants valued information given by consultants at diagnosis but some 
acknowledged that the stresses experienced at diagnosis meant much of this information 
was not fully understood or was forgotten. Written information provided seemed to be 
little more than contact telephone numbers for use in the case of an emergency.  
 
MC participants stated that information was provided on their diagnosis, and the range of 
drug treatments that were available to them within the clinic. In all cases, information 
regarding the possible side effects of anti-dementia treatments was also provided, 
combined with methods of coping with these side effects, and contact details should side 
effects become too serious for the patient or carer to cope with.  MC participants felt 
well-informed regarding side effects, and knew what to expect about the likelihood and 
severity of any problems. MC participants were predominantly satisfied with the 
information they had been provided, although some participants thought that more 
written information should be provided at diagnosis, which could be referred to later. 
 
However, most participants (irrespective of service) identified other information needs.  
Carers needed information on how to cope with emotional and behavioural changes in 
patients. Participants highlighted a lack of information on the range of financial support 
available to them. They felt that gaining access to financial assistance from social 
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services and local authorities was a long, complex and difficult process, which might 
often result in more isolated elderly patients or carers not making a claim: 
 
‘I am fairly mobile and vocal when it comes to things like that.  But the 
little old lady on the top floor of a tower block of flats without a phone 
may be struggling… It can sort of be a lonely situation to be in, and you 
start thrashing about for information on how to deal with problems or 
where to get help.  Or Benefits, I mean that is a minefield’ (MC carer). 
 
MC participants felt they received little or no assistance in access to these services. 
Further gaps in information included other support services available such as day and 
respite care. 
 
Satisfaction with information provided 
While relatively little information was provided by the MMS, what information was 
provided was useful and relevant. High levels of satisfaction were also expressed with the 
information given to them through the informal referral process existing between the 
MMS and the Huddersfield branch of the Alzheimer’s Society. Several participants had 
received assistance from the MMS nurses in completing assessment forms for the range 
of financial and other benefits available. This was particularly valued by participants 
because of the complexities involved in the process of submitting claims for benefits. 
One carer, satisfied with the treatment and verbal support gained from the MMS, was 
dissatisfied with information available on treatments for Alzheimer’s disease prior to 
referral to the MMS.  She only became aware of treatment for Alzheimer’s, from a TV 
programme, after her husband had suffered from the disease for four years: 
  
‘I see the GP quite regularly and he had not told me anything about 
tablets, Aricept or any tablet, any medication at all for Alzheimer’s 
disease.  I did not know there was such a thing, until I saw it on the 
television.  Seems a bit hard, to find out through the telly but… it seemed 
so wrong to me that there could be help there and we had not the 
knowledge to get it’ (MMS carer). 
 
Satisfaction with the type of information provided by the memory clinic was generally 
low, with participants unhappy with the lack of information on the availability of external 
support and services. Participants were satisfied with information on diagnosis and 
treatment options, although in one case criticisms were made regarding the way in which 
the diagnosis was communicated and the overwhelming amount of information given.  
 
Several carers noted a lack of information on how to adapt to changes in the behaviour of 
their partners, particularly how to cope with challenging behaviour. Carers who 
complained about this said the knowledge they had gained was a result of trial and error: 
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‘I have learnt the hard way… If you deal with something incorrectly, it 
can have a detrimental effect to her.  It has a tremendous knock on effect 
to her.  And nobody explained this to me at the outset.  So you go 
through tremendous ups and downs, you know where you get things 
wrong, and it affects the patient tremendously, more than it would in 
normal times’ (MC carer). 
 
Several participants thought that the memory clinic would provide a perfect opportunity 
for information on this area to be shared.   
 
While many MC carers stated that the clinic should provide some support for carers, a 
small minority of carers were less certain as to whether this provision fell under the remit 
of the clinic, given its primary function in providing diagnosis and treatment for the 
patient. When questioned on this issue, several MC carers initially were unsure as to 
whether the clinic should provide clinical or information based assistance to carers: 
 
‘I do not think anybody has actually said ‘how are you coping?’ They 
have just been interested in how (wife) is and is she better or worse… I 
am not sure whether I would expect them to ask me that… should the 
clinic care whether the carer is coping? I do not know whether they 
should really… they certainly have not taken an interest in me, and until 
you have just mentioned it I had not thought it was odd’ (MC Carer). 
 
While carers acknowledged their own health problems, and in several cases attributed 
them to the burden of caring, few felt that the memory clinic should be involved in them. 
Carers were more likely to contact their own health practitioners, rather than approach 
clinic staff.  This may result in an increased burden upon carers and other health 
practitioners who do not possess specialist knowledge in the area of dementia care. 
 
The lack of information provided by both services placed the onus in gaining access to 
information upon the carer. Younger carers felt that many their elderly counterparts 
might lack the knowledge and drive to access relevant information sources: 
 
‘I am young, I have got a car, I can afford petrol to get somewhere, but 
some little old lady… is going to struggle with this system.  It must be a 
hell of a struggle for them, even finding out how to get benefits and who 
to ask to fill the form in’ (MC carer). 
 
Generally, younger carers of patients with early onset dementia were more critical of the 
information provided. Older carers were more accepting of the limited information given.  
This was attributed to a variety of factors including the lack of knowledge about 
particular information sources, a lack of skills needed to access the Internet, and a 
deferential wish not to inconvenience staff. In this respect, the memory clinic was seen to 
be an important regular contact point for participants, where there was potential for other 
needs to be more rigorously assessed, and assistance offered where necessary.   
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Communication style 
 Most participants were satisfied with communication with clinical staff and valued the 
empathy they experienced.  When probed, some participants preferred the informal and 
individualised approaches that nurses adopted. All emphasised the friendliness of the 
MMS nurses.  One carer emphasised the humorous banter that occurred between her 
husband and the MMS nurse.  According to this carer, this showed not only her 
husband’s improved cognition, but also his feelings of ease and comfort with the nurse: 
 
‘The nurse is excellent and she could not be better at the job because she 
is casual, she is not formal, she is completely informal, and she has a 
good laugh with you, and makes a joke of it as much as (husband) does.  
You could not ask for anything better than that in my opinion’ (MMS 
carer). 
 
Many felt that the nurses valued and treated them as individuals, rather than simply as 
patients. Several MMS carers expressed that nurse visits were events to look forward to, 
much in the same way that carers would express anticipating a visit from social contacts: 
 
‘In fact I look forward to it, and I try to make the best of my appearance, 
because she is always so attractively dressed and she makes the best of 
herself, as we all should.  And I was sorry, I felt I have lost another 
friend, and that is how I feel about losing (MMS nurse) and that is how I 
feel, both in her work, and as a person, I feel I have lost a friend’ (MMS 
carer). 
 
This carer was apprehensive regarding the reduction in frequency of visits by the MMS 
nurse due to the success of treatment. Many patients and carers felt socially isolated.  
Within this context of social isolation, visits from the MMS nurses provided patients and 
particularly their carers with an important opportunity for social contact.  
 
Most MC participants were satisfied with the level and range of communication with 
staff within the clinic.  Clinic staff were viewed as friendly and helpful.  Patients 
highlighted this when discussing the nurses: ‘They were very good; we were there 
about two hours. But they were very good with the interview and everything’.  (MC 
patient). Although each nurse was complimented, some carers felt unable to build a 
relationship with staff, owing to the distribution of patients to different nurses.  This was 
particularly important at the earlier stages, where patients and their carers might be 
making frequent visits to the memory clinic for assessment and monitoring of side 
effects.  This contrasted with patients and carers who visited the single nurse consultant 
and usually highlighted his friendliness and the continuity of care.  This opinion may 
have been strengthened by the fact that carers had more contact with the nurse consultant 
than with other nurses or doctors. Many MC carers had a hierarchical understanding of 
the clinic, its operations and the positions of staff working within the clinic.  This shaped 
how they viewed the roles of different professional staff, and how they communicated 
with professionals within the clinic.  Many MC carers felt that they had little formal 
communication with nursing staff, as nurses usually tested patients in the absence of 
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carers.  Several carers felt that psychiatrists were too important to ‘waste their time’ 
providing information to patients and carers. Instead, it was thought that a nurse or 
someone could provide this information. Clearly, this unwillingness to approach senior 
staff, combined with small amounts of contact with nurses might have influenced the 
opportunity that carers had to communicate all their concerns to staff. 
 
One MC carer was strongly dissatisfied with how the diagnosis of dementia was 
communicated to the patient.  The diagnosis was given to the patient without the carer.  
The carer said this caused emotional distress for the patient and felt this method of 
communicating the diagnosis was cruel to the patient.  He felt that he should have been 
present while the diagnosis was discussed to provide emotional assistance and support.   
 
Satisfaction with external information sources 
Of the ten patient and carer pairs seen, eight were in regular contact with Alzheimer’s 
Society.  Once the Society had been contacted, it became the main source of support and 
information about the disease. Participants enthusiastically expressed their satisfaction 
with the information provided.  There appeared to be good integration between the MMS 
and the Society, where the MMS provided diagnostic information, then put participants in 
touch with Alzheimer’s Society:  
 
‘The nurse does not give me any written information… I get all my 
information through the Alzheimer’s society.  I get the national 
newsletter, which comes out about every three months and when my 
husband was first diagnosed, the Alzheimer’s society gave me a booklet 
with everything in it so I am kept up to date with what is going on by the 
Alzheimer’s society rather than the memory service’ (MMS carer). 
 
While most carers were in contact with the Society, ‘referral pathways’ into the Society 
from the MC were erratic.  Participants had made contact independently of the memory 
clinic and other health services, discovering the society through friends or family, or 
through their own research.  Within the MC, some staff appeared to inform all patients 
about the Society while others did not.  Some staff appeared to be mistaken regarding 
who could be referred to the Society. Some participants claimed that they had been told 
that only patients with Alzheimer’s disease could be referred. Only one carer had been 
encouraged to make contact with the Alzheimer’s Society by MC staff.  
 
Several patients attended an early stage support group organised within the local branch 
of the Society.  They had increased contact with MMS nurses through their presence at 
support groups and other meetings the Society held.  This provided a further important 
opportunity for carers and patients to build less formal relationships with the nurses. 
Little direct integration appeared to exist between the MC and the Alzheimer’s Society.   
 
 
 
 25
Memory matters: A report exploring issues around the delivery of anti-dementia medication 
                                                                                                                                                    
 
3.7 Summary 
 
Patients and carers understood dementia to be a consequence of old age possibly 
augmented by the stress of life events. They coped with behavioural changes prior to 
diagnosis by trying to “normalize” them and deny difficulties. Often some crisis caused 
the carer to approach the GP leading to referral to the memory services. 
 
Community contact was valued. In the service designs studied, the community service 
(MMS) also tended to provide more continuity of care. When this continuity was 
provided in the clinic setting (MC) it was also appreciated. The community service 
minimised potential stressors associated with having to travel to a hospital setting, 
especially if the hospital had bad historical associations. At home, service users could be 
more relaxed and able to complete assessments and talk more freely about their day to 
day life experiences and any worries. Waiting times for access to the services were 
generally acceptable and compared favourably with other NHS services but excessive 
waiting within clinic caused frustration in both services, though it appeared to be more 
frequent in one pathway through the MC that involved separate appointments with doctor 
and nurse. Participants were generally well satisfied with the benefits of drug treatment 
and appreciated the need for formal assessments. They appreciated the personal qualities 
of staff and valued being seen by the same person repeatedly, especially in the early 
stages of engagement with the services. They enjoyed the individualized friendly service 
characteristic of the MMS and of the pathway through the MC where they saw the 
consultant nurse. They generally found it easier to relate to nurses than doctors. Neither 
service was particularly good on information provision. Overall, the MC appeared to 
provide more detailed medical information and, through links with Alzheimer’s Society, 
the MMS dealt better with information on practical approaches to behaviour problems, 
benefits and other services. 
 
These findings were tested in a larger sample through the questionnaire phase of the 
study.  
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4 
Objective 1:  Alzheimer’s Society Representative 
Interview Findings 
 
 
4.1 Introduction 
 
We interviewed two representatives of the Alzheimer’s society at their places of work 
(the Huddersfield branch and the Wakefield branch). Semi-structured interviews 
facilitated freedom of discussion. Interviews lasted from thirty to forty five minutes. We 
identified four main themes and a range of related themes (Table 4.1). 
 
Table 4.1 Summarised Alzheimer’s society representatives’ coding template 
 
FIRST LEVEL THEME LOWER LEVEL THEMES 
1. Perceived memory service staff 
views of the society 
1.3 Lack of shared understanding of the populations served 
by the society and the aims of the service 
1.4  Integration issues 
2. Treatment location  2.1 The community based model 
2.2 The hospital based model 
3. Satisfaction with the service  3.1 Support 
3.2 Individualised service 
4. Information provision 4.1 Range of information provided 
4.2 Satisfaction with information provided 
4.3 Communication style 
 
4.2 Perceived memory service staff views of the society 
 
The Alzheimer’s Society representatives expressed their perceptions of how they thought 
the memory service staff viewed the work of the Society. We identified two main sub-
themes; a lack of shared understanding of the populations served by the society and the 
aims of the service and integration issues. 
 
Lack of shared understanding of the populations served by the society and its aims 
Interviewees reported that many patients and carers using the Wakefield service had been 
ill advised as to who could access the Society. The Wakefield representative reported 
instances of people contacting the branch for advice about what other organisations they 
could access because their diagnosis of dementia was not Alzheimer’s disease: 
 
 
 27
Memory matters: A report exploring issues around the delivery of anti-dementia medication 
                                                                                                                                                    
 
‘On a number of occasions I have had people telling me that they did not 
think they could access our service because they do not have Alzheimer’s 
disease. I think the problem is that many of the doctors these people are 
seeing also think that the Alzheimer’s Society is just for people with 
Alzheimer’s Disease’ (Wakefield representative). 
 
Both thought that it was mainly doctors who promoted this misunderstanding. They 
suggested that the memory services and the Society could collaborate to increase 
awareness of the Society as a resource for all patients with dementia and their carers. 
 
Integration issues 
Both representatives discussed integration issues. The community model adopted by the 
Huddersfield service had maintained an efficient referral process. The MMS staff 
informed all their patients of the Alzheimer’s Society. In many cases they made links 
with the society on behalf of patients and carers: ‘The memory monitoring unit send us 
I think more or less everybody that goes through… they mostly get sent to us’ 
(Huddersfield representative). Many patients and carers were being reached by the 
Society via the MMS. Indeed, the Huddersfield representative was more concerned for 
individuals who had not accessed the MMS and how the Society was to reach them.  
 
The Wakefield representative believed there could be better integration between the 
Wakefield branch and the memory clinic. She argued that if the memory clinic were a 
community service, the referral process to the Alzheimer’s Society would be more 
efficient because the visiting nurse could introduce the society and provide contact 
details. The presence of a representative from the Alzheimer’s Society within the 
memory clinic would be a costly but positive move for the Wakefield Memory Service: 
 
‘In an ideal world with lots of funding… if the clinic remained hospital 
based it would be ideal if we had a presence in clinic to follow patients 
and be there for their information and support needs at each stage… if it 
developed into a community service well then I think our referral system 
would work better, because if we were informed of everyone we could 
keep in contact’ (Wakefield representative). 
 
4.3 Treatment location 
 
We questioned representatives regarding the service operating within their area. They 
each had views about the appropriateness of each service model for patients and carers. 
 
The community based model 
Both representatives had a preference for a community based memory service model. 
They reported that many families had difficulties persuading the patient to attend clinic 
because the patient does not feel that there is anything wrong with them. Patients and 
their families were put at ease if a professional came out and saw them in their own 
homes: ‘Families really struggle to get them to hospital… so being able to say that 
someone is coming out to you I think is a really good thing’ (Huddersfield 
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representative). Many patients and their carers felt isolated after a diagnosis and 
uncomfortable about entering a clinical situation. The burden of being diagnosed with a 
mental illness was lessened if both patient and carer were able to strike up a friendly 
relationship with a memory nurse: ‘I think having the same psychiatric nurse coming 
regularly helps them… I feel really sorry for those who are not receiving the service’ 
(Huddersfield representative). Those individuals who were not involved with the MMS 
had more fears and worries when they accessed the Alzheimer’s Society. Regular home 
attendance from a memory nurse gave individuals the support they needed to be able to 
adjust to a diagnosis of dementia and associated behavioural changes.  It also helped meet 
their information requirements either directly or through referral to the Society. 
 
The hospital-based model 
Families were said to find it difficult to persuade patients that they needed to attend 
clinic. The age of the patient population and the local history surrounding the hospital site 
added to their anxiety: ‘We have struggled to get through to some people, I mean one, 
they are not ready to admit that they need to go to a mental health hospital and 
there is nothing wrong with them…’ (Huddersfield representative). Historically, the 
mental health hospitals in the area were workhouses and mental asylums. Patients and 
carers found it difficult to come to terms with attending these stigmatised environments.  
 
There were also reported complaints about delays occurring for patients and carers within 
the Wakefield clinic. The representative reported to have received numerous letters from 
people complaining about distress caused by having to wait in clinic for a number of 
hours: ‘several carers have said that their partners have been distressed by the 
amount of time they have had to wait in clinic as well’ (Wakefield representative). 
Though delays are sometimes unavoidable, there was a fear that carers would begin to 
question the benefits of treatment in relation to the stress incurred in clinic attendance. 
 
4.4 Satisfaction with the service 
 
Both representatives expressed satisfaction and dissatisfaction with different aspects of 
the local services. We identified two main themes: Support and individualised service. 
 
Support 
The Wakefield representative thought that insufficient time was spent with patients and 
especially carers in clinic. Some complaints had been received by the Society about 
carers being separated from patients and feeling as if their experience was not valued:  
 
‘In general what carers feel is that they do not have the time to talk to 
anyone about what is happening at home. They would ideally like to talk 
to someone about the things that have been happening at home in the last 
month and how things have changed but they do not get the chance to do 
that’ (Wakefield representative). 
Ideally, the representative argued, more time should be given to carers in consultations. 
However, she realised that time and financial constraints made this difficult to achieve: 
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‘I think things are moving in the right directions, purely because the staff 
realise the gaps in their provision… they know they should be looking at 
the full picture but currently don’t have the resources to do that… at 
present it does appear that they only have the time and resources to sort 
out the right drug treatment’ (Wakefield representative). 
 
The Huddersfield representative said that patients and carers appreciated the high level of 
support they received from the MMS. They saw the nurses as companions to whom they 
could voice their concerns.  Both representatives reported that staff facilitated support 
groups at the Society branches.  
 
Individualised service 
The MMS seemed to offer a more individualised service. Frequent home contact by the 
same professional promoted trust and limited anxiety for both patients and carers:   
 
‘They remember their name, which is something a lot of carers cannot 
remember, the names of the psychiatric nurses. They probably see them 
infrequently. Whereas because they see more of them, you know they’ve 
got more contact they remember their names’ (Huddersfield 
representative). 
 
The clinic-based service had a more narrow medical focus with little time available to 
concentrate on the wider issues that might influence treatment adherence and care. 
 
4.5 Information provision 
 
Issues surrounding information frequently recurred over the duration of each interview. 
We identified two main themes: Range of information provided and communication style. 
 
Range of information provided 
The Society had a lot of information on dementia, ranging from physiological 
information to information about the social effects of dementia and help available: 
 
‘They get an information pack about local services… and they get a book 
as well… and then we have fact sheets about all aspects of elderly life, 
with Age Concern… and then we have all the Alzheimer’s Society fact 
sheets… so we’re a resource really, we’ve got a library, a video… so 
anything they want, from the simplest of information to the more in 
depth we have got’ (Huddersfield representative). 
 
If all patients and carers were referred to the Society, it could provide information for 
many of their needs. If specific information about drug treatments was needed the 
representatives would refer to the memory services. Although the Society held texts on 
drugs for dementia, representatives did not want to provide out of date information: 
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‘The one thing we do not do is dabble in the drugs side of it… if there 
were any questions on drugs or problems with drugs I would turn to the 
memory monitoring unit for that… and I have never not been satisfied 
with what they have provided… and I have not heard of complaints’ 
(Huddersfield representative).
 
The representatives thought they were viewed by the memory services, at least by those 
who understood the purpose and aims of the Society, as an information resource for 
patients and carers. The representative in Wakefield feared that many people were not put 
in touch with the Society to receive the information they needed: 
 
‘I do not know if it is down to the time limitations within clinic or what 
but it is quite frustrating how many people have not received anything… 
we are well known to the staff but we have found that people get mixed 
messages’ (Wakefield representative). 
 
The MC and the Society are developing a pack of information to distribute at clinic: 
 
‘Information is improving… when people are sent to us we pick out the 
information they need… because of this experience we are working with 
the clinic to put together an information pack that can be given out at 
clinic’ (Wakefield representative). 
 
Communication style 
Both representatives noted that patients came from a generation with unconditional 
respect for medical staff. Once referred to the Society, patients and carers would tend to 
use it as the first point of contact for any query, so as not to disturb the nurse or doctor: 
 
‘I think sometimes people might find it difficult picking up the phone 
and phoning such as the nurse, because she is a nurse, but I think that is 
the way of the world. We are probably seen as less intimidating. But the 
fact that the link is there we can ring for them… sometimes they think 
they are pestering, you know, they don’t think they have the right… it’s 
a generation that doesn’t ask’ (Wakefield representative). 
 
This was more often the scenario in Wakefield. Perhaps this reflected the more formal 
relationships there as opposed to the more informal relationships in the MMS. 
 
4.6 Summary 
 
In summary, a good relationship was reported between the MMS and the Huddersfield 
branch of the Alzheimer’s Society. The Society appeared to possess the defined role of 
information provider and all patients and carers using the MMS were referred to the 
Society for this purpose. No complaints had been received by the Society with regard to 
the MMS service design. The informal nature of the service model strengthened the 
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success of the service and helped patients and carers to dissociate dementia from the 
historical stigma of the local mental hospitals and workhouse buildings. 
 
The MC service design did not enable sufficient time to be spent on carer needs. Carers 
disliked being separated from patients within clinic and felt that their experience was not 
valued. Waiting times within clinic were also a problem for patients and carers. Referral 
to the society in Wakefield needed improving, in that not all MC staff referred to the 
society or understood its purpose. Due to the identified difficulties, however, work was in 
progress to develop an information pack with the Society to distribute at clinic.  
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5 
Objective 1:  Professional Focus Group Findings 
 
 
 
 
5.1 Introduction 
 
A total of 10 professionals participated in two focus groups conducted at their place of 
work. The length of the discussions ranged from forty to ninety minutes. Of the 
professionals interviewed, three were doctors, three were clerical staff and four were 
nurses.  
 
Participants identified positive aspects of recent service developments as well as a range 
of problems and gaps associated with the current organisation and delivery of care, in line 
with the views of patients, carers and the Alzheimer’s society representatives. Themes 
were identified as detailed in Table 5.1.  
 
Table 5.1 Summarised professional focus groups’ coding template 
 
FIRST LEVEL THEME LOWER LEVEL THEMES 
1. Service focus 2.3 Drug treatment 
2.4 Future needs 
2. Strengths 4.3 Service model 
4.4 Integration with other services to meet patient needs 
3. Weaknesses 3.1 Awareness 
3.2 Information provision and meeting carer needs 
3.3 Waiting times and staffing 
 
5.2 Service focus 
 
Participants of both focus groups discussed the focus of their service. Two distinct 
themes pertained to this area of discussion: Drug treatment and Future needs. 
 
Drug treatment 
The MC was seen as, a service focused on dementia assessment and the provision of anti-
dementia drugs and an integral part of wider older people’s services. Similarly, the MMS 
primary focus was seen as the prescribing and monitoring of anti-dementia medication: 
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‘Our main job is to assess the patient, provide the medication and 
monitor it… but that doesn’t mean we ignore other things that may be 
affecting the patient or their carer, but yes our role is to provide and 
monitor the medication really’ (MMS participant). 
 
However, it was realised that the patients and professionals from other services might 
think the service had a wider focus. Time and financial restrictions limited the degree of 
care that could be provided by each service. Despite frustrations, participants of both 
focus groups thought their services were operating well and adhering to the service plan. 
 
Future needs 
Despite the narrow focus of each service around drug treatment staff acknowledged that 
wider care issues were often addressed. Referrals to other services were important and 
attention was given to the coping and adjustment difficulties of both patient and carer: 
 
‘We do not have an awfully long time to spend with these patients and 
carers on things other than obtaining the information through 
conducting the different tests… but what I can say is that through 
talking through for example the MMSE with the patient and even just 
having a short discussion with the carer, we can pick up on other issues 
and, if we feel it necessary, we can then refer them on to other 
professionals or services… obviously we do not see the full picture as you 
would through a home visit’ (MC Participant). 
 
Future service development should concentrate on a memory service providing a more 
complete package of care. Ideally, this would involve the provision of psychosocial 
interventions for patients and carers, the provision of more detailed information and other 
professionals feeding into the community service or having presence within the clinic to 
enable more detailed assessments and to provide a coherent multidisciplinary service. 
 
5.3 Strengths 
 
All participants were eager to emphasise the strengths of their services. We identified two 
main themes: Service model and Integration with other services to meet patient needs. 
 
Service model 
Staff within the MC had received a positive response from all stakeholders with regard to 
the structured diagnostic process and the community nursing aspect of the service: 
 
‘Through the development and continued success of the memory clinic 
we have had a lot of feedback from other clinicians and staff, the 
structured diagnosis process is viewed very positively and the more 
recently evolved community nursing element of our service has been 
welcomed’ (MC Participant). 
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Staff thought that the service was viewed as already ‘comprehensive’, friendly and 
accessible amongst fellow NHS personnel. 
 
MMS staff were more focused upon the strengths of the service with regard to patient and 
carer needs. There was consensus that the service was succeeding because of its 
flexibility. The community focus meant that patients were seen in their own homes at 
times most suitable for them. A home based service provided staff with a more accurate 
clinical picture, as patient and carer could be seen in the context of their everyday lives: 
 
‘I think we benefit from the service being a community service as well 
as the patients and carers… we are flexible as to when we can visit, if 
patients want us to visit in the evening or even at weekends we do and 
they are happy with that… and I think because we do go out and we 
go out and see them in their own homes we can really make a more 
realistic assessment… for example we see how they are coping, how 
they are living, if they can make a cup of tea when they say they can 
you know’ (MMS Participant). 
 
Integration with other services to meet patient needs 
Both focus groups agreed that the level of integration they have with other services could 
be improved. Ideally, each service would be more holistic in focus, drawing on the 
expertise of varied professionals. The risk of loss of continuity of care was not 
emphasised. Participants of the MMS focus group claimed that they had forged good 
links with the local branch of the Alzheimer’s Society. All participants agreed that they 
viewed the Society as a referral point for information. This could be a two way process in 
that the Society would also inform unknowledgeable individuals about the MMS: 
 
‘We have quite a good working relationship with the Alzheimer’s 
Society… everyone we see we mention the support that they could get 
from them and either put them in contact with the society or with 
permission pass on the patient details ourselves to the society… and the 
process works both ways really… if they get enquiries about our service 
or they think someone may benefit from our service then they contact us’ 
(MMS Participant).
 
Participants of the MC focus group were aware of the work of the Alzheimer’s Society 
and referred to support work staff members facilitated with the Society: 
 
‘We do run support groups at the Alzheimer’s Society… it is something 
additional to our work here because we recognise the benefit these 
patients and carers can receive from participating in a support group… 
ideally we would have more time in clinic to provide psychosocial 
interventions’ (MC Participant). 
 
They acknowledged that improved integration was needed. Current time, financial and 
space restrictions prevented the presence of an Alzheimer’s representative in the clinic.  
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5.4 Weaknesses 
 
Despite the strengths of each service being highlighted, all participants were aware of 
weaknesses in their service structure and delivery. Three themes were highlighted: 
Awareness, information provision and meeting carer needs, waiting times and staffing. 
 
Awareness 
Participants of the MMS focus group argued that despite many GPs in the area now being 
aware of the MMS they did not all understand that they could refer directly to the service: 
‘It is surprising that still not all GPs realise that they can refer directly to the 
service’ (MMS Participant). Staff recognized the need to promote direct referral but 
thought that higher staffing levels would be required to achieve this. Similarly, MC 
participants sometimes experienced misunderstandings regarding referrals. Despite 
efforts to promote the aims and purposes of the memory clinic and the general support 
amongst NHS staff for the service, inappropriate referrals were still received. 
 
Information provision and meeting carer needs 
Neither service provided any formal therapeutic input for carers. MMS participants 
argued that on an informal level they made sure that carers were coping with their 
situation and provided verbal information. They referred all patients and carers to the 
Alzheimer’s society for further information and support. At the MC, carers were asked to 
fill in caregiver burden questionnaires but participants acknowledged that insufficient 
time was available to discuss lengthy carer issues. In defense of this situation, staff 
repeated that the main focus of the clinic was to provide drug treatment to the patient. 
The understanding was that other services were in place to attend to the wider needs of 
both patient and carer: ‘We do pick up some of the other problems that the patient or 
carer may experience but really it is the remit of other agencies to identify and 
attend to these’ (MC Participant). Understanding the current situation however, 
participants suggested that the way forward would be to provide more integrated services. 
 
Waiting times and staffing 
Participants of the MC focus group discussed the difficulty of waiting times within clinic 
combined with the further difficulty of transport waiting times. There were also 
difficulties matching up nursing and medical appointments. Despite these weaknesses of 
the current MC design participants argued that the clinic basis of the service enabled 
them to achieve the balance between the needs of patients, carers, staff, health and safety 
and cost effectiveness: 
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‘We do incur problems in relation to waiting times in clinic… if 
transport is delayed and our first patient is late well that can knock us 
out for the rest of the day… we also have two systems working, one 
whereby the patient will just see the nurse consultant and the other 
whereby they will see both a nurse and psychiatrist and so for these 
patients they may have a longer wait because they have two 
appointments… I can imagine in comparison a community service 
would avoid such but it maybe would not be as cost effective, as safe 
or practical in consideration of psychiatrist case loads and equipment 
costs and safety issues for example’ (MC Participant). 
 
Indeed due to the success of the service and increase in patient numbers, efforts had been 
made to reduce waiting times by increasing staff numbers.  
 
MMS participants were concerned about staffing. They argued that, despite the success of 
the MMS and the rapidly increasing number of patients within the service the staffing 
remained limited. If staff numbers were not significantly increased, waiting times that are 
currently acceptable would rapidly increase: 
‘So far the service has been very successful and our patient numbers 
are forever increasing, if we are not careful we risk our success by not 
being able to cope with the patient increase because the staff numbers 
are staying the same’ (MMS Participant).  
 
Indeed, the main theme and concern that ran through the discussion of both focus groups 
was their future staffing capacity and ability to meet the future needs of patients, 
especially in view of the possible future licensing of drugs for advanced dementia. 
 
5.5 Summary 
 
Participants from both services argued that their main purpose was to provide and 
monitor anti-dementia drug treatments. They were not ignorant of the patient or carers 
wider needs. If needs were identified, they were not hesitant to refer to other services. 
However, participants from both services claimed that a more multi-disciplinary 
approach to memory care could only serve to improve and strengthen current service 
designs. Current strengths to each design were identified, including good diagnosis, 
assessment and patient monitoring processes, and in the case of the MMS their level of 
working integration with the Alzheimer’s Society. Reported weaknesses pertained to 
insufficient time, space and funding. Ideally, there would be more time and funding for 
staff to promote the services, and professionals and interventions in place to improve 
information provision and support for both patients and carers. Furthermore, waiting 
times in clinic were a problem and staffing in both services an issue if patient numbers 
were to continue to increase. 
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6 
Objective 1 : Questionnaire Findings 
 
 
 
 
6.1  Introduction 
 
This section provides a summary of the results of a statistical analysis of questionnaires 
distributed to patients, carers and GP’s using the MC or the MMS. Questions were 
designed to address themes arising from a preliminary analysis of qualitative data 
collected during patient and carer interviews.  Nominal and ordinal methods of ranking 
data were generally chosen to promote ease of understanding and response for patients 
and their carers, while also retaining a level of differentiation between responses 
(Diamantopoulos & Schlegelmilch 1997). 
 
Sixteen questions were developed based upon the five main objectives of this stage of the 
study.  Patients and their carers were also given the opportunity to express in writing any 
concerns relating to the service they received.  We conducted a qualitative analysis of 
these comments. Statistical analysis was conducted on the raw data but, because of the 
different response rates, results in tables are given as percentages for easy comparison.  
Implications of differences in response rates are discussed fully within the discussion 
section of this report.  Results were recorded and analysed using the Statistical Package 
for Social Sciences (SPSS) Version 11.  Questionnaires were analysed by frequency 
count, the Chi Square statistic, and the Mann Whitney U test. Where appropriate degrees 
of freedom are also provided.  Where differences in the number of degrees of freedom 
occur, this is a result of differences in either the number of responses available for an 
individual question, or because of no participants using either service entering a response 
for a particular variable.  In some cases tables of results have been condensed for brevity.  
Full statistical results are available in the web version of this report. 
 
6.2 Patients’ and carers’ questionnaires 
 
Response rates 
 
One hundred and twenty two responses were received from patients and carers, 30 (25%) 
from the MC and 92 (75%) from the MMS.  Response rates were 30/190 (16%) for the 
MC and 92/225 (41%) for the MMS. Differences between response rates and the 
generally low overall response rate mean the results should be viewed with caution.   
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6.2.1 Satisfaction with the service 
 
General Satisfaction with service   
 
Participants using the two services were asked to give their general levels of satisfaction 
with the service they received. Answers are summarized in table 6.1 
 
Table 6.1 Satisfaction with memory service. (n = 122) 
 
 Memory Clinic (%) MMS (%) 
Very Happy 26.7 34.8 
Happy 43.3 51.1 
Neither happy nor unhappy 10.0 10.9 
Unhappy 20.0 1.1 
Very unhappy 0.0 2.2 
 
High proportions of participants were either happy or very happy with the two services; 
with significantly fewer participants expressing unhappiness with the MMS Differences 
in determining levels of satisfaction amongst users of the two services did not reach 
statistical significance. (Mann Whitney U = 1121.5, p<0.094).  
 
Satisfaction statements 
 
Eight statements were used to evaluate the level of participant satisfaction with particular 
aspects of the service. A five point Likert scale was used; with responses ranging from 
strongly agree to strongly disagree.  The results are shown in table 6.2: 
 
Table 6.2 Percentage of participants agreeing/strongly agreeing with satisfaction 
statements.  
 
Statement Memory 
Clinic (%) 
MMS 
(%) 
P 
value 
a.  The patient gets a benefit from being seen by the 
service (n = 122) 
73.3 80.4 0.411 
b.  The carer gets a benefit from being seen by the service 
(n = 120) 
80.0 76.1 0.494 
c.  I am happy with the amount of time spent with us on 
appointments (n = 121) 
73.4 83.7 0.714 
d.  I am satisfied that staff can help with the patients 
memory problems (n = 122) 
63.3 76.0 0.203 
e.  The service asks about the health and wellbeing of the 
carer (n = 118) 
46.7 57.7 0.145 
f.   I am happy with how we receive the drugs given to us by 
the service (n = 122) 
76.7 91.3 0.01* 
g.  The length of time we had to wait before being seen by 
the service caused us problems (n = 122) 
13.3 14.1 0.696 
h. The purpose of the tests was explained to me. (n = 121) 76.6 81.5 0.374 
* P value significant at 5% level or higher 
 
Responses to these statements were generally positive, with most participants either 
agreeing or strongly agreeing with the above statements. Most participants using both 
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services either disagreed or strongly disagreed that waiting times were a problem. 
Statistically significant differences were found in only one case, with higher levels of 
satisfaction with the MMS service occurring in respect of processes for supplying 
medication (Mann Whitney U = 988.5 p <0.01). 
 
6.2.2 Timeliness 
 
Perceived length of waiting times  
 
Table 6.3 Perceived waiting times prior to first 
appointment with memory services. (n = 115) 
 
 Memory Clinic (%) MMS (%) 
Less than 1 month 10.0 16.3 
1-2 months 36.7 44.6 
2-3 months 16.7 22.8 
Over 3 months 33.3 9.8 
missing 3.3 6.5 
 
The highest proportion of patients in both services reported waiting between one and two 
months.  Waiting times appeared to be significantly higher amongst individuals using the 
memory clinic (Mann Whitney U = 933.5, p<0.05)  While 33 % of Memory Clinic 
service participants stated that they had to wait over 3 months for treatment, only 10% of 
MMS participants reported waiting this long.  Perceived waiting times were falling 
within both services, with recently referred patients more likely to have been seen 
quickly. Since this is not a systematic sample of patients not much significance can be 
attached to this finding but both services were making efforts to reduce waiting times 
prior to this study (Hassan 2002, SWYT 2002).   
 
Frequency of check up appointments 
 
Participants were asked how frequently they would like repeat assessments within each 
memory service (see table 6.4). 
 
Table 6.4 Desired frequencies of repeat assessments.  (n = 122) 
 
 Memory Clinic (%) MMS (%) 
Every 1-2 months 26.7 4.3 
Every 2-3 months 10.0 19.6 
Every 3-4 months 23.3 21.7 
Every 4-5 months 6.7 2.2 
Every 5-6 months 20.0 40.2 
Less than every 6 months 10.0 7.6 
 
While differences were found between the two services, these did not reach statistical 
significance (Mann Whitney U = 993.5, p = 0.64). Little uniformity in the distribution of 
individual opinions regarding repeat assessments was found in those using both services. 
Within the MMS, 40% of participants appeared to be satisfied with the current six 
monthly post efficacy assessment appointments, compared to only 20% of MC 
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participants.  In contrast, 26.7% of MC participants desired regular monthly checks, 
compared to just 4.3% of MMS participants.  
 
Table 6.5 Percentage of participants agreeing/strongly agreeing with timeliness 
statements (n = 122) 
 
Statement Memory 
Clinic (%) 
MMS 
(%) 
P value 
a.  I am happy with the length of time we had to wait until 
out first appointment 
66.7 71.7 0.389 
b. I am happy with the length of time we had to wait 
between appointments. 
53.3 70.6 0.006* 
c. Appointments with staff take up too much of our time. 23.0 2.2 0.044* 
* P value significant at 5% level or higher.  
 
Participants in both services appeared to be satisfied with the length of time between 
repeat assessments.  However, satisfaction with the period between repeat assessments 
was higher amongst MMS users and their carers, with 70.6% of MMS participants giving 
positive responses regarding the length of time between appointments, compared to 
53.3% of MC participants.  Differences were also found to be statistically significant 
(Mann Whitney U = 953.0, p<0.01).   
 
Relating to length of appointments within each memory service, statistically significant 
differences were found in favour of participants using the MMS (Mann Whitney U = 
1073.5, p<0.05).  This may be partly due to traveling time, and waiting time as well as 
time spent face to face with staff. 
 
6.2.3 Treatment Location 
 
Satisfaction with location of treatment 
 
Participants were asked a range of questions relating to their satisfaction with the location 
in which treatment was received, reflecting the differing clinic and community focus of 
the two services. 
 
Table 6.6 Satisfaction with treatment location. (n = 122) 
 
 Memory Clinic (%) MMS (%) 
Very happy 20.0 51.1 
Happy 43.3 38.0 
No opinion 20.0 5.4 
Unhappy 16.7 3.3 
Very unhappy 0.0 0.0 
 
Participants were generally satisfied with the location used by their service. Higher levels 
of satisfaction were found amongst participants using the MMS.  The proportion of MMS 
participants who were either happy or very happy with receiving treatment at home was 
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significantly higher than the proportion of participants expressing similar levels of 
satisfaction with the clinic (Mann Whitney U = 771.0, p<0.01). 
 
Satisfaction with treatment location statements 
 
Five Likert scale statements were designed to gain information on different aspects of 
satisfaction with treatment location.  These are summarised in table 6.7.    
  
Table 6.7 Percentage of participants’ agreeing/strongly agreeing with treatment 
location statements. 
 
Statement Memory 
Clinic (%) 
MMS 
(%) 
P value 
a.   Traveling to clinic causes/would cause problems for 
us.  (n = 121) 
10.0 57.6 0.0001* 
b.   Seeing staff at home/in clinic makes the patient 
anxious. (n = 122) 
30.0 3.3 0.006* 
c.   Staff spend enough time with us during appointments 
(n = 122) 
80.0 82.6 0.983 
d.   I would prefer to be seen by staff at home. (n = 121)  40.0 80.5 0.0001* 
e.   I would prefer to be seen by staff in clinic (n = 121) 56.7 1.1 0.0001* 
* P value significant at 5% level or higher 
 
Differences in attitudes regarding traveling to clinic were found to exist within this 
sample.  MMS participants commonly felt that difficulties in traveling to clinic would 
cause significant problems for them.  However, MC participants who regularly attended 
clinic as part of their treatment did not commonly express this concern.  These results 
were highly significant (Mann Whitney U = 689.5, p<0.01).  
 
Statistically significant differences were detected relating to levels of anxiety felt by 
participants; with fewer MMS participants reported feeling anxious about appointments 
when compared to memory clinic users.  (Mann Whitney U = 980.5 p<0.01).   
 
Participants from both services were generally happy with the amount of contact they had 
with staff.  Few expressed any dissatisfaction with the length of appointments, or the 
level of contact with staff.  No statistically significant differences were found to exist 
between participants using the two services. 
 
Statistically significant differences were detected relating to preferences for treatment 
location amongst participants using the two memory services (d; Mann Whitney U = 
659.0, p<0.01. e; Mann Whitney U = 607.0, p<0.01). Generally participants appeared to 
specify a preference for the service they currently received, with 80.5% of MMS 
participants preferred to be seen at home, compared to 40% of memory clinic 
participants. In contrast, 56.7% of MC participants preferred the clinic-based service they 
currently receive, compared to just 1.1% of MMS participants. While participants 
generally appeared to state a preference for the familiar, differences in levels of 
preference can be seen.  Nearly all MMS participants preferred a community-based 
service, whilst opinions of MC users were more varied.   
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6.2.4 Information Provision 
 
Information provided by the service 
 
Participants were invited to complete six questions about the range and amount of 
information provided by the memory service they used and by other services.  These 
questions also covered their satisfaction with information received and satisfaction with 
the methods by which information was communicated.  Questions about information 
were a major part of the questionnaire, with 6/15 questions relating to this issue. 
 
Information sources for service users 
 
Six sources of information were identified from interviews.  Participants were asked to 
indicate whether they had received any information or support from each of the sources. 
 
Table 6.8 Information sources used by participants. 
 
Sources Memory Clinic (%) MMS (%)  
 Yes No Yes No P value 
a.  Memory Clinic/Service (n = 121) 50.0 50.0 88.0 10.9 0.001* 
b.  CPN’s/CMHT’s (n = 121) 36.7 63.3 46.7 52.2 0.312 
c.  G.P.s (n = 120) 23.3 76.7 50.0 47.8 0.008* 
d.  Alzheimer’s Society (n = 120) 46.7 53.3 50.0 47.8 0.673 
e. Other charities for older people (n 
= 120) 
3.3 96.7 10.9 87.0 0.201 
f.  Other (n = 119) 13.3 86.7 9.8 87.0 0.625 
* P value significant at 5% level or higher  
 
MMS participants appeared to be more commonly in receipt of information from health 
services and other organizations. Differences were statistically significant in favour of the 
MMS in respect of two sources; the memory service (Mann Whitney U = 832.5, p<0.01), 
and GP’s (Mann Whitney U = 975.0, p<0.01). Amongst participants using both services, 
approximately half were in contact with the local Alzheimer’s society. 
 
Information provided by memory services 
 
These issues were developed into nine statements, divided into two distinct groupings: 
 
Group 1:  Diagnostic and treatment information needs. Statements 12a-d 
Group 2.  Support & Psychosocial information needs.   Statements 12e-i 
 
Group 1 statements related to information about how the service operated, the diagnosis 
given, and the range and effects of drug treatments available.  Group 2 statements related 
to formal and informal support that might be required by patients or carers, information 
regarding financial benefits, and information on how to cope with changes that the onset 
of dementia brings.  Participants were asked to identify whether they had been provided 
with any information in each of these areas by the memory service they used. 
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Table 6.9 Range of information received from memory services. (n = 120) 
 
 Memory Clinic MMS  
Statement Yes 
(%) 
No 
(%) 
Yes 
(%) 
No 
(%) 
P Value 
a. How the memory 
clinic/service operates  
53.3 43.3 71.7 20.7 0.02* 
b. Diagnosis of memory 
problems given to the patient  
40.0 46.7 57.6 30.4 0.08*  
c. Treatments available  60.0 36.7 70.7 16.3 0.038* 
d. Possible side effects of 
treatment 
53.3 43.3 75.0 15.2 0.002* 
e. Financial help available to 
patient/carer 
16.7 73.3 42.4 41.3 0.004* 
f. Help with care available to 
patient 
10.0 80.0 33.7 53.3 0.008* 
g. Help with care available to 
carer 
10.0 83.3 33.7 50.0 0.004* 
h. How to cope with changes 
in life due to memory problems 
3.3 93.3 26.1 57.6 0.003* 
i. Changes to expect in future 20.0 66.7 21.7 50.0 0.488 
* P value significant at 5% level or higher  
 
Group 1 Needs: statements a-d. Differences in favour of the MMS were statistically 
significant in all four areas: information on how the service operated (chi square =5.409, 
d.f. = 1, p<0.05), Diagnosis of memory problems provided to the patient (chi square = 
4.311, d.f. = 1 p<0.05) treatment options (chi square = 6.780, d.f. = 1, p<0.05), side 
effects of treatment (chi square =9.183, d.f. = 1, p<0.05)  
 
Group 2 Needs: statements e-i.  Information provided about practical and psychosocial 
support was relatively low in both services but statistically significant differences were 
found in favour of the MMS in four out of five statements; information on financial 
benefits (chi square = 8.455, d.f. = 1, p<0.05); help with care available to patients, (chi 
square 7.113, d.f. = 1, p<0.01); help with care available to carers (chi square =8.186 d.f. = 
1, p<0.01) and information on how to cope with changes in behaviour found in patients 
(chi square =8.982, d.f. = 1, p<0.05).   
 
A question was also included regarding how easy information provided by the memory 
service was to understand.  We included an option to select ‘no information received’.  
 
Table 6.10 Was information provided by 
memory services easy to understand? (n = 85) 
 
 Yes 
(%) 
No 
(%) 
Memory Clinic 36.7 16.7 
MMS 72.8 2.2 
 
Where participants received information, significant differences were recorded regarding 
ease of understanding of this information.  (chi square = 13.815, d.f. = 1, p<0.01). 
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Respondents were questioned regarding whether the services provided written contact 
details should carers need to contact staff in an emergency.   
 
Table 6.11 Percentage given any written contact 
details for the memory service? (n = 112) 
 
 Yes No 
Memory Clinic 46.7 33.3 
MMS 83.7 12.0 
 
Written contact details were more regularly provided to patients and their carers by the 
MMS.  This difference was statistically significant (chi square = 10.530, d.f. = 1, 
p<0.01). 
 
Satisfaction with information provided by the memory service 
 
Respondents were asked to answer six Likert scale statements relating to their satisfaction 
with the range and level of information provided by the two memory services, and with 
the nature of communication they had with the service.   
 
Table 6.12 Percentage of participants agreeing/strongly agreeing with 
information/communication statements. (n = 122) 
 
Statement Memory 
Clinic (%) 
MMS 
(%) 
P 
a.  Memory clinic/service provides information on the 
patient’s memory problems 
63.3 51.0 0.118 
b. Staff are friendly and informal when talking to me. 100.0 88.0 0.685 
c.  I feel comfortable talking to the staff I see  96.6 90.2 0.412 
d. Staff show concern for the health and wellbeing of the 
carer. 
66.7 55.4 0.245 
e.  Staff listen to and answer my questions 93.4 73.9 0.152 
h. Staff tell me about other places and groups where I can 
get help. 
10.0 29.4 0.091 
 
As shown in table 16, participants were generally satisfied with both the information they 
were provided with by the two memory services, and with the range and type of 
communication they had with memory service staff.  In particular the communicative 
abilities of memory service staff were highlighted.  In most cases higher levels of 
satisfaction were recorded amongst participants in contact with the memory clinic.  
However these were not statistically significant.  Both services appeared to perform 
poorly in respect of providing information on other services, with only 10% of MC 
participants and 29.4% of MMS participants either agreeing or strongly agreeing that the 
services provided information on other services. 
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6.2.5 Participants’ comments 
 
At the end of the questionnaire participants were given the opportunity to make 
comments. Comments were received from 25 participants, predominantly from carers.  
18 commenting on the MMS, 7 on the MC.  Comments varied from single sentences to 
short letters.  Comments also varied in content, but were generally congruent with 
findings from the qualitative survey and questionnaire.  In some cases comments 
appeared to be unrelated to the services, but served to illustrate general concerns amongst 
people with dementia and carers about health and social assistance.   
 
MC comments 
 
Comments on the MC were mainly negative.  Several carers noted that they received 
little support from the service.  Two comments compared unfavourably the support 
provided to people with dementia and carers to support provided for cancer sufferers. 
 
 ‘People I have spoken to feel very much on their own. Compared with 
say the support that cancer sufferers and carers receive’. (Carer, MC). 
 
 ‘When you compare the service provided with say the service provided 
to someone who has cancer (terminal or not) it is not very good.  There 
is no overall plan and it is not patient orientated’. (Carer, MC). 
 
Two individuals noted the performance of professional staff within the clinic. Both 
praised members of the nursing staff for the assistance they provided.  However one was 
highly critical of some of the doctors previously active within the memory clinic. This 
carer’s experience of some staff within the clinic resulted in a dislike of attending: 
 
 Some of the large number of doctors have been very good, many have 
been appalling … Nursing staff at the clinic were brilliant.  I almost 
made an official complaint about one of the doctors as his attitude and 
behaviour was so dismissive of (patient).  To be fair one or two of the 
doctors were good but you know you would not see them again and I 
used to get so worked up and full of dread going wondering what to 
anticipate that the really bad ones just dominated. (Carer, MC). 
 
In this case the largely negative experience of the clinic was also expressed as part of a 
more general negative experience of overall care and assistance provided to people with 
dementia and their carers.  While individuals and organisations such as the Alzheimer’s 
society were highlighted for praise, institutional systems of support were heavily 
criticised as being bureaucratic and insensitive to the needs of patients: 
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 ‘With the worst there has been no sensitivity to (patient) at all.  Nursing 
staff have been superb.  After the distress some put her through I would 
have chosen not to go to the clinic but it is a necessary hoop to jump 
through, to access the support.  The Alzheimer’s Society have provided 
more support, helpful intervention, insight and decent common sense 
than anyone…we have managed to get round the many blocks put in 
our way by a system apparently designed to confuse, depress and 
destroy. (Carer, MC). 
 
MMS comments 
 
In the case of the MMS, comments made by participants were generally positive.  Most 
participants who made comments were complementary about the staff visiting them as 
part of the service they received. 
 
‘I very much appreciate the care and concern shown by members of 
the memory monitoring service who have visited me’. (Patient, MMS). 
 
 
One carer highlighted that the home visits enabled him to carry on working, as absences 
for clinic appointments were not required: 
 
 ‘As things are my wife can care for herself to some degree.  She can see 
the MMS nurse on her own whilst I am at work.  If we had to go to a 
clinic I would have to take time off work to go with my wife and this 
would cause difficulties for me at work’. (Carer, MMS). 
 
However several comments were either critical of the service or questioned the 
effectiveness of the treatment they received.  Where participants were critical of the 
service, this was often as a result of a paucity of information provided: 
 
 ‘I was pleased to have a diagnosis and an opportunity for my mother to 
be prescribed medication but the six monthly monitoring appointments 
with the nurse have been of no real benefit to me or my mother apart 
from allowing the service to determine the suitability of continuing the 
medication’. (Carer, MMS) 
 
 ‘A little more information needed on progress’. (Carer, MMS). 
 
  ‘I do not think I have enough information from the service though their 
visits are appreciated and the staff very friendly’. (Carer, MMS). 
 
One participant criticised the service about a lack of communication and reported that 
they were not informed regarding visits by staff, treatments given and other issues. 
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 ‘My mother was simply put onto Aricept by the MMS after the GP 
suggested she might be suitable.  The MMS just visit her at intervals at 
home.  Neither me nor my sister are advised of when they are going 
(sometimes this includes Sundays!!), nor are we advised of the results.  
(…) I consider the lack of communication from the MMS to be very 
bad and it seriously concerns me. (Carer, MMS). 
 
This comment was against the general trend of comments and while it cannot be 
discounted, may represent an idiosyncratic experience. 
 
6.2.6 Summary  
 
The questionnaire results identify a number of interesting issues. 
 
Responses rates were higher amongst MMS participants, with a response ratio of 
approximately 3:1 compared to the MC. This may have reflected more accurate recent 
contact lists provided by the MMS or a generally greater degree of engagement with the 
MMS. It means that results have to be interpreted with caution. 
 
Patients and carers participating in this questionnaire were generally satisfied with both 
services.  While general trends showed higher levels of satisfaction amongst individuals 
using the MMS, these did not reach statistical significance.   
 
Perceived waiting times for both services were approximately 1-2 months, with longer 
waiting times reported by MC participants.  Fewer MMS participants reported waiting 
times of 3 months or more.  Waiting times appeared to be falling within both services.  
Participants appeared to be satisfied with the length of time they had to wait prior to 
contact with the service, with no significant differences between services.  Patients and 
carers were satisfied with the length of appointments, with higher rates of satisfaction 
occurring amongst participants using the MMS. 
 
Participants were generally satisfied with the location in which they received treatment.  
Higher levels of satisfaction were recorded amongst individuals using the MMS. Patients 
and carers commonly preferred the type of service they received, and disliked possible 
alternatives.  This finding was stronger amongst MMS participants who gave higher 
levels of satisfaction with aspects of the MMS service when compared to participants 
using the MC. 
 
The memory services were the most common source of information for participants.  
More information appeared to be provided by MMS staff.  Where information was 
provided by the services, this was focused on the design and operation of the service, 
diagnosis of dementia and treatment options available. Fewer participants reported that 
information relating to their everyday practical and psychosocial needs was provided.  
When provided by services, the MMS appeared to provide significantly more information 
in these areas. 
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Written comments showed that participants were often positive regarding the care they 
receive from health care professionals, especially nurses.  In both the MC and the MMS 
this was seen as a positive aspect of the service.  However within the MC and to a lesser 
extent within the MMS, concerns were raised regarding the amount of information 
provided.  Criticisms were also made regarding general care services provided for people 
with dementia, which were seen by some individuals as more of a hindrance than a help. 
 
6.3 General practitioner questionnaire findings 
 
6.3.1 Introduction 
 
This section provides a summary of the results from the questionnaire distributed to 
general practitioners who referred patients to the memory services involved in this study.   
 
Issues of interest were identified using the same methods used for patient and carer 
questionnaires.  Questionnaires were developed using qualitative analysis of interviews 
conducted with patients, carers and staff, and as a result of a preliminary analysis of 
questionnaires to patients and carers.  Piloting took place prior to the distribution of the 
questionnaire.  Initially, in order to recruit referring GPs, carers completing the 
patient/carer questionnaire were asked to provide details of their referring GP and/or 
consultant.  Because of problems with differences in sample sizes for the two services, 
alternative sampling methods were used.  In the case of the MMS, a list of referring GPs 
was provided by nursing staff within the service.  This resulted in a total sample of 82 
referring GPs within the MMS catchment area.  Of these 82 GPs, 17 responded, giving a 
response rate of 20.7%.  In the case of the GPs referring to the memory clinic, 
questionnaires were sent to the practice managers of surgeries within the MC catchment 
area.  A total of 140 questionnaires were sent to these practices.  Of these GPs, 25 
responded, giving a response rate of 17.9%.  Of these responses, 4 stated that they had 
not referred any patients to the MC, and thus were removed from the analysis.  Problems 
arising from these sampling methods will be further considered in the discussion chapter. 
 
A total of six questions related to the five main objectives of the study.  Each used a five 
point Likert scale, with responses ranging from very satisfied to very dissatisfied.  
Written comments were invited at the end of the questionnaire. 
 
Results were analysed as for the patient and carer sample by comparing satisfaction 
scores, and through the use of Mann Whitney U test to test for and compare significant 
differences. 
 
 
Satisfaction with the memory service 
 
Participants were asked to rate satisfaction with the overall quality of the service.  
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Table 6.13 GP satisfaction with memory services.  (n = 37) 
 
 Memory Clinic (%) MMS (%) 
Very satisfied 9.5 11.8 
Satisfied 71.4 76.5 
Neither Satisfied or dissatisfied 14.3 11.8 
Dissatisfied 0.0 0.0 
Very Dissatisfied 4.8 0.0 
 
Satisfaction was high for both services with no statistically significant differences. (Mann 
Whitney U 162.5 p = 0.543) 
 
 
Satisfaction with waiting periods for the two services 
 
Participants were asked to give a level of satisfaction with the waiting period between 
referral and first appointment for the service they used. 
 
Table 6.14 GP satisfaction with waiting times.  (n = 36) 
 
 Memory Clinic (%) MMS (%) 
Very satisfied 0.0 0.0 
Satisfied 19.0 47.1 
Neither Satisfied or dissatisfied 47.6 41.2 
Dissatisfied 19.0 11.8 
Very Dissatisfied 14.3 0.0 
 
Many GPs were ambivalent about the waiting times for the services.  Significant 
differences were detected in the spread of answers given by GP’s, highlighting higher 
levels of satisfaction amongst GP’s using the MMS (Mann Whitney U = 100.0, p>0.05). 
Five GPs commented that waiting times were a problem in the MC: 
 
‘The wait between the first appointment and second appointment is too 
long, hence delaying the commencement of treatment’. (GP, MC) 
‘Long Waiting List.  Low use of Aricept’. (GP, MC) 
‘Usual problem is how long patients have to wait both for initial 
assessments by the nurse and then the wait for the clinic appointments’. 
(GP, MC) 
 
Only one GP using the MMS commented that waiting times were a problem. 
 
Satisfaction with treatment location 
 
Participants were asked to give their level of satisfaction with the location of the service. 
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Table 6.15 GP satisfaction with treatment location (n = 38) 
 
 Memory Clinic (%) MMS (%) 
Very satisfied 9.5 11.8 
Satisfied 57.1 76.5 
Neither Satisfied or dissatisfied 23.8 11.8 
Dissatisfied 9.5 0.0 
Very Dissatisfied 0.0 0.0 
 
Levels of satisfaction were high. There were no statistically significant differences (Mann 
Whitney U = 139.0, p = 0.168).  Only one GP commented on service location, 
acknowledging that patients might face difficulties in getting to the clinic: 
 
‘Can be difficult to get the elderly to the clinic particularly early morning 
in Wakefield but do get assessed at home as well’. (GP, MC). 
 
Satisfaction with information provided to patients and carers 
 
GPs were asked to give their levels of satisfaction with the amount of information that the 
service provided to patients and their carers. 
 
Table 6.16 GP satisfaction with information provided to patients (n = 37) 
 
 Memory Clinic (%) MMS (%) 
Very satisfied 17.6 14.3 
Satisfied 64.7 47.6 
Neither Satisfied or dissatisfied 17.6 38.1 
Dissatisfied 0.0 0.0 
Very Dissatisfied 0.0 0.0 
 
GPs were generally satisfied with the levels of information that both services provided to 
patients and their carers. Differences were not statistically significant (Mann Whitney U 
= 142.0, p = 0.338). 
 
Satisfaction with information provided to GPs 
 
GPs using the two services were asked seven Likert scale questions relating to the range 
and type of information they were given by staff in the two memory services. Generally 
little dissatisfaction was recorded amongst GPs using both services. 
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Table 6.17 Percentage of GP’s satisfied/very satisfied with information provided by 
service. (n = 38) 
 
Statement Memory 
Clinic (%) 
MMS 
(%) 
P value 
a.   How the Memory Clinic/ Service operates 23.8 70.5 0.019* 
b.   Referral methods to the service 42.9 76.5 0.031* 
c.  Range of treatments available to patients with 
dementia 
23.8 58.9 0.018* 
d. Effectiveness of treatments available to patients with 
dementia 
19.0 23.5 0064 
e.  Possible side effects of drugs given to the patient 19.0 35.3 0.084 
f.  Range of interventions available for caregivers of 
dementia patients 
14.3 53.0 0.003* 
g. Range of external support services available to 
patients and their carers. 
9.6 64.7 0.004* 
* P values significant at 5% level or higher 
 
Significant differences regarding the level of information provided to GPs were found in 
favour of the MMS for five items: how the service operated (Mann Whitney U = 96.5, 
p<0.05), referral methods to the service (Mann Whitney U = 110.0 p<0.05), range of 
treatments available to people with dementia (Mann Whitney U = 100.5, p<0.05), range 
of interventions available for caregivers of dementia patients (Mann Whitney U = 83.5, 
p<0.01) and the range of external support services available to patients and their carers 
(Mann Whitney U = 85.5,  p<0.01).  In all cases statistically higher rates of satisfaction 
were found amongst GP’s referring patients to the MMS. 
 
When GPs commented about the level of information provided to them by the memory 
services several noted that communication with the MC could be improved.   
 
‘Not enough info on what is available’. (GP, MC) 
‘Provides a very good service but communication between them and us 
could be improved’.  (GP, MC) 
 
Similarly, three GPs felt uncertain about how the clinic operated the position and role of 
GPs with respect to the clinic, and the prescribing of medication by the memory clinic.   
 
‘Often uncertainty whether they will prescribe anti-dementia drugs as 
patients and carers come to us for them after memory clinic initiates’. 
(GP, MC) 
‘Not quite sure about follow-up arrangements sometimes when patients 
are on medication’. (GP, MC) 
‘I am unclear as to the range of options available’. (GP, MC) 
 
Satisfaction with shared care protocol arrangements 
 
Finally, GPs were asked to give their levels of satisfaction with the arrangements for 
shared care between the memory services and primary care trusts. 
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Table 6.18 GP satisfaction with shared care protocol arrangements. (n = 38) 
 
. 
 Memory Clinic (%) MMS (%) 
Very satisfied 0.0 11.8 
Satisfied 38.1 47.1 
Neither Satisfied or dissatisfied 47.6 29.4 
Dissatisfied 9.5 5.9 
Very Dissatisfied 4.8 5.9 
 
Few GPs appeared to be dissatisfied with existing arrangements.  Trends in favour of the 
MMS did not reach not statistical significance (Mann Whitney U = 136.5, p = 0.185) 
 
6.3.2 Summary 
 
GPs were generally satisfied with both services.  While satisfaction was slightly higher 
with GPs using the memory monitoring service, this difference was not significant. GPs 
appeared to be neither satisfied nor dissatisfied with the length of waiting times found 
within both memory services.  Higher levels of satisfaction with waiting times were 
recorded amongst GPs using the MMS, though these did not reach statistical significance.  
Several GPs expressed written concerns relating to the length of waiting times within the 
MC. GPs using each service were satisfied with the location in which the particular 
service they referred patients to was based. GPs were satisfied with the level of 
information that the memory services provided to patients and carers.  With respect to 
information provided to GP’s, significant differences were detected in favour of the 
MMS in two areas: information on how the service operated, and information provided to 
people with dementia and carers on the range of external support services and agencies. 
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7 
Objective 3: The Clinical Audit 
 
 
 
 
 
7.1 Introduction 
 
The main objective of this section was to check compliance with NICE guidance with 
respect to assessment, inclusion criteria, monitoring, review and withdrawal of treatment. 
Routine clinical records in each service were examined against a schedule of NICE 
guidance.  
 
Consent for permission to examine the medical records of service users was sought as 
part of the questionnaire distributed to patients and their carers.  Records were selected 
according to the following inclusion criteria: 
 
• Presence of probable dementia of Alzheimer’s type 
• Currently receiving anticholinesterase drug treatments. 
 
Patients who had been removed from treatment, or who were presenting with vascular or 
other forms of dementia were excluded.  Patients presenting with both dementia of 
Alzheimer’s type and vascular dementia who were receiving treatment with 
anticholinesterase drugs were included.   
 
Checklists identifying the criteria for diagnosis and the prescribing, monitoring and 
discontinuation of anticholinesterase drugs were developed from NICE guidance and 
used in anonymous audit of records from the two services.  The case notes of consenting 
individuals were then examined according to these criteria.  To increase numbers, data 
were combined with anonymous data from clinical audits using the same criteria in both 
services. Data were analysed using SPSS Version 11.  
 
7.2 Audit Results 
 
The records of 78 MMS patients and 67 MC patients were identified and audited.  The 
mean age of patients using the Memory Clinic was 78.07 (range 60-92, sd 6.79), while 
the mean age of patients using the MMS was 79.13 (range 59-97, sd 8.68, NS). 
 
All three anticholinesterase drugs currently licensed were available within both services.  
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Compliance with NICE guidance  
 
The findings are given in table 7.1.  
 
Table 7.1 Clinical audit of compliance of memory services with NICE guidance. 
(NICE 2001). 
 
 Compliance with NICE Guidance 
NICE Guidance Standards Yes 
(%) 
No 
(%) 
Don’t Know 
(%) 
N/A 
(%) 
 MMS MC MMS MC MMS MC MMS MC 
Diagnosis made in a 
specialist clinic 
100 100 0 0 0 0 0 0 
Standard baseline 
assessments before 
treatment  
100 98.5 0 1.5 0 0 0 0 
Assessment conducted in 
specialist clinic  
100 100 0 0 0 0 0 0 
Likelihood of compliance 
with treatment assessed 
100 100 0 0 0 0 0 0 
Presence of 
carer/careworker to ensure 
compliance guaranteed. 
100 100 0 0 0 0 0 0 
Treatment initiated by 
specialist 
100 91.0 0 0 0 0 0 9.0 
Carer opinions (CGI) 
included in consultant 
assessment 
98.7 85.1 1.3 6.0 0 0 0 9.0 
3-4 month efficacy 
assessment taken place 
96.2 71.6 0 1.5 2.6 1.5 1.3 25.4 
Repeat assessments 
conducted at 6 month 
intervals 
96.2 71.6 0 1.5 2.6 1.5 1.3 25.4 
*Prescribing passed over to 
shared care protocol 
93.6 0 2.6 0 2.6 0 1.3 100 
* Memory clinic retains control over prescribing drug treatments.  Treatment not transferred under shared 
care protocol 
 
7.3 NICE Guidance Criteria 
 
Diagnosis of Alzheimer’s disease made in a specialist clinic according to standard 
diagnostic criteria 
 
Specialist assessment and diagnosis of Alzheimer’s disease was made in all cases in both 
services.  In the MC, the diagnosis and decision on suitability for treatment took place 
during baseline assessments.  In the MMS, diagnosis and decision on suitability for 
treatment took place in a regular local outpatient’s clinic external to the service.    
 
All diagnoses were based on standard diagnostic criteria.   As the two services used 
different detailed assessments, these were audited for compliance with local standards. 
 
 55
Memory matters: A report exploring issues around the delivery of anti-dementia medication 
                                                                                                                                                    
 
Assessment in a specialist clinic, including tests of cognitive, global and behavioural 
functioning and of activities of daily living 
 
Compliance with guidance to determine cognitive, global and behavioural functioning 
was high, with assessments taking place in all cases for both services.  While both 
services used assessments that complied with guidance, each used a different range of 
assessments.  Both used a variant of the Mini Mental State Examination and a standard 
scale to measure activities of daily living.  However the memory clinic used a greater 
range of cognitive and other measures during assessments.   
 
Clinicians exercise judgement about the likelihood of compliance with treatment 
 
During assessments the likelihood of compliance with treatment was assessed in all 
cases.   Clinicians were shown to ascertain and assess the presence of a care-worker or 
informal carer able to ensure compliance with treatment in all recorded cases.   
 
Only specialists should initiate treatment 
 
A specialist initiated treatment in all cases.  Observations from carers were considered in 
most baseline assessments; with 98.7% of MMS cases and 85.1% of MC cases showing 
evidence that carer opinion were included in assessments.  Where carer opinions were not 
included, this was indicated as being due to the absence of a carer during assessments.  
Where carers were not present arrangements were noted in patient’s records for carers to 
be consulted at a later date either by telephone or during further assessments. 
 
2-4 month efficacy assessment conducted 
 
An efficacy assessment at 2-4 months was conducted in 96.2% of cases within the MMS, 
and 71.6% of cases within the MC.  Where efficacy assessments had not been conducted, 
this was usually because patients had only recently been placed upon treatment, and had 
not yet reached the first efficacy assessment.  This accounted for 25.4% of audited cases 
within the memory clinic.  Three measures were identified within NICE guidance to be 
used to ascertain efficacy at 2-4 months;  
• improvement/stability in MMSE score, plus 
• improvement in activities of daily living and/or 
• observed improvement in abilities by carer. 
 
Compliance was high within both services.  No cases were recorded where patients who 
were non compliant with all three measures at the first efficacy assessment were 
continued on treatment.  
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Table 7.2 Compliance with 2-4 month efficacy assessment. 
 
 
 
 
Compliance with NICE Guidance 
NICE Guidance Statements:  2-4 Month 
Efficacy Assessment 
Yes (%) No (%) Don’t Know (%) 
 MMS MC MMS MC MMS MC 
MMSE Stabilised/Improved  94.8 88.0 2.6 10.0 2.6 2.0 
Improvement in activities of daily living 67.5 70.0 28.6 20.0 3.9 10.0 
Observed improvement in ability from 
carer 
85.7 74.0 3.9 20.0 10.4 6.0 
 
Different measures of activities of daily living were used by the two services so that 
despite similar percentages, results may not be directly comparable.  Observed 
improvements by carers were recorded as taking place in 85.7% of cases within the 
MMS, compared to 74.0% of MC cases.  Cases within the Memory Clinic where 
compliance was not achieved were from newer patients who had not yet reached the first 
efficacy assessment.  These cases were recorded as N/A. This accounted for 25.4% of 
cases within the Memory Clinic.  Results marked as N/A have been removed to reflect 
frequencies of audited cases reaching the first efficacy assessment. 
 
Transfer of prescribing under shared care protocol 
 
Prescribing was passed over to GPs under shared care protocol arrangements within the 
MMS in 93.6% of cases.  As the MC retained control over the prescribing of anti 
dementia medication, no cases occurred where prescribing was transferred to GPs. Since 
the study Wakefield has adopted a shared care protocol based on that used in 
Huddersfield. 
 
Repeat assessments at 6 month intervals with treatment only continued if MMSE 
>12 
 
Compliance was high in both services with well over 90% MMS and about three quarters 
of MC patients having repeat assessments. Those not receiving repeat assessments in the 
MC were at an earlier stage of the process.  Only 2% MC and 2.6% of MMS participants 
scored less than 12. Both service protocols allowed for patients with MMSE scores below 
12 to be given treatment if a trial withdrawal caused deterioration. In these cases efficacy 
was assessed using an alternative measure.  
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7.4 Audit of services for compliance with local standards 
 
Use of standard diagnostic criteria 
 
Table 7.3 Use of standard diagnostic criteria. 
 
 Compliance with Standards 
Local Standards Yes 
(%) 
No 
(%) 
Don’t Know 
(%) 
N/A 
(%) 
 MMS MC MMS MC MMS MC MMS MC 
Standard baseline 
assessments before 
treatment  
100 98.5 0 1.5 0 0 0 0 
Psychiatric History 98.7 97.0 0 3.0 1.3 0 0 0 
Physical examination 0 * 83.6 0 16.4 0 0 100 0 
Height/Weight 0 4.5 0 95.5 0 0 100 0 
Urinalysis 0 34.3 0 65.7 0 0 100 0 
Blood tests 87.2 77.6 5.1 22.4 7.7 0 0 0 
CT Scan 26.9 65.7 69.2 34.3 2.6 0 1.3 0 
ECG 82.1 6.0 14.1 94.0 3.8 0 0 0 
Nursing assessment 98.7 97.0 0 1.5 1.3 1.5 0 0 
Carer opinions gained at 
baseline assessment 
98.7 91.0 0 7.5 1.3 1.5 0 0 
* Shared care protocol made this a GP responsibility  
 
 
Both services used a range of standardised assessments in diagnosing patients.  The MC 
performed a wider range of assessments, conducting physical examinations and urinalysis 
more commonly than the MMS.  As part of the shared care protocol arranged between 
primary care and old age services within Huddersfield, physical examinations and other 
assessments were conducted by general practitioners prior to referral to the MMS.  
Psychiatric assessments, nursing assessments and consultation with carers during 
assessments occurred in most cases.  All three assessments occurred in 98.7% of cases 
within the MMS.  Psychiatric assessments and nursing assessments took place in 97% of 
cases within the MC, while consultation with carers took place in 91% of cases.   
 
Blood tests, Electro-cardiograms (ECG’s) and Computerised Tomography (CT) scans 
were not used in all cases in either service.  Significant differences were found.   
 
Blood tests were conducted in most cases, with significantly more tests conducted on 
patients using the MMS (MMS 87 % vs. MC 78%, chi square = 13.746, d.f. = 2, 
p<0.001).  Greater variations in the frequency of CT scans were found between the two 
services, with the MC much more likely to conduct a CT scan (MMS 27%, MC 66%, chi 
square = 22.916, d.f. = 3, p<0.0001).  Consultants assessing patients within the MMS 
referral pathway were much more likely to have ECG’s (MMS 82.1% vs. MC 6.0%, chi 
square = 92.178, d.f. = 2, p<0.0001).  Variations in usage of blood tests, ECG’s and CT 
scans reflect differences in service design and practice between the MMS and the MC.  
ECGs are mostly performed to reduce risk from possible cardiac side effects of 
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cholinesterase inhibitors.  CT scans are mostly performed for diagnostic reasons. A long 
waiting time in Huddersfield at the time of the study discouraged their use. 
 
Assessment in a specialist clinic, including tests of cognitive, global and behavioural 
functioning and of activities of daily living 
 
Table 7.4 Cognitive, functional and behavioural assessment measures used within 
the memory services. 
 
 Compliance with Standards 
Local Standards Yes 
(%) 
No 
(%) 
Don’t Know 
(%) 
N/A 
(%) 
 MMS MC MMS MC MMS MC MMS MC 
Assessment conducted in 
specialist clinic  
100 100 0 0 0 0 0 0 
Cognition (MMSE/SMMSE) 98.7 95.5 0 1.5 1.3 0 0 3.0 
Depression. (Geriatric 
Depression Scale) 
0 92.5 0 4.5 0 0 100 3.0 
Activities of daily living  98.7 95.5 0 1.5 1.3 0 0 3.0 
Behaviour  
(BEHAVE-AD) 
0 92.5 0 4.5 0 0 100 3.0 
Stage of dementia (Global 
Deterioration Scale) 
0 16.4 0 80.6 0 0 100 3.0 
Carer Stress (Screen for 
Caregiver Burden) 
0 89.5 0 7.5 0 0 100 3.0 
Critical Flicker Fusion & 
Reaction time 
0 71.6 0 25.4 0 0 100 3.0 
 
The MC used a more comprehensive battery of cognitive, functional and other measures 
than the MMS, reflecting its stronger research orientation. The clinic routinely used six 
instruments to assess patients and carers at baseline: the Standardised Mini Mental State 
Examination (SMMSE) (Molloy et al 1991), Geriatric Depression Scale (GDS) 
(Yesavage et al 1983), Bayer Activities of Daily Living (B-ADL) (Hindmarch et al 
1998), Behavior Pathology in Alzheimer's Disease (BEHAVE-AD) (Reisburg et al 1987), 
Screen for Caregiver Burden (SCB) (Vitaliano et al 1991) and Critical Flicker Fusion & 
Reaction Time (Curran & Wattis 2000).  These tests were used in the majority of cases, 
with SMMSE, GDS, B-ADL, and BEHAVE-AD being used in over 90% of cases.  
Critical Flicker Fusion was used in 71.6% of cases.  In addition, the Global Deterioration 
Scale was used in 16.4% of cases.  The range of tests generally complies with the original 
memory clinic service model.   
 
In comparison the MMS used a less rigorous regime of assessments, with only two 
instruments conducted at baseline; the Mini Mental State Examination (MMSE) (Folstein 
et al 1975) and Bristol Activities of Daily Living (BADL) (Bucks et al 1996).  These 
measures comply with the original service protocol for the MMS (SWYT 2002).  These 
tests are also routinely used during each repeat assessment along with an opportunity for 
the chief relative or caregiver to give a global impression of change.  
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Side Effects Check and Dose Titration 
 
Table 7.5 Frequency of side effects checks within both memory services 
 
 Compliance with Standards 
Local Standards Yes 
(%) 
No 
(%) 
Don’t Know 
(%) 
N/A 
(%) 
 MMS MC MC MMS MC MMS MC 
1 month side effects check 
conducted 
97.4 64.2 0 10.4 2.6 6.0 0 19.4 
Nurse/clinic visit to make 
side effects check & dose 
titration 
32.1 64.2 62.8 9.0 5.1 1.5 0 25.4 
telephone call to make side 
effects check & dose 
titration 
62.8 0 32.1 0 5.1 0 0 100 
MMS 
 
Assessment of any side effects resulting from treatment was conducted in most cases for 
users of both memory services.  Side effect checks were conducted in 97.4% of cases 
within the MMS, and 64.2% of cases within the MC.  While a large difference between 
the two services appears to have been recorded, 19.4% of audited cases within the MC 
had not yet reached this stage of treatment, and thus were recorded as Not Applicable 
(N/A).  Side effects assessments were not conducted in 10.4% of cases within the MC.  
This figure is significantly higher than recorded in the MMS, where no cases were 
recorded where side effect checks were not conducted.  Amongst patients using the 
MMS, side effects checks were made by telephone in 62.8% of cases, with home visits in 
a further 32.1% of cases. Side effects checks within the MC when conducted were almost 
universally clinic based. 
 
7.5 Audit Summary 
 
Both services operated at high rates of compliance with NICE guidance.  While the two 
services were based upon different modes of treatment provision, both were highly 
compliant with NICE guidance.  
 
As noted previously, variations occurred in the use of baseline diagnostic assessments 
between the services.  The MC used CT scans more often, while the MMS in contrast 
used ECGs far more often.  The MC also conducted a wider range of cognitive and other 
assessments, reflecting its research orientation.  Both services conducted assessments of 
side effects relating to drug treatments.  However, in 10% of cases within the Memory 
Clinic side effects checks did not formally occur until the first efficacy assessment.  Side 
effects checks within the memory clinic were usually more comprehensive, taking place 
within a full clinic assessment, whereas in the MMS, side effects checks were commonly 
conducted via a telephone call.   
 
Both the MC and the MMS were fully compliant with measures used to ascertain efficacy 
of treatment.  All patients complied with the NICE guidance regarding continuance of 
treatment at the first efficacy assessment held at 2-4 months.   
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8 
Objective 4: Cost Analysis 
 
 
 
8.1 Assessing intervention costs 
 
We estimated the costs of staff time and diagnostic tests from hospital costing data and 
by consulting hospital finance staff and the managers of the services concerned. 
 
Table 8.1 Costing categories. 
 
Costing categories: 
*Staff time 
consultations 
transactions 
*Diagnostic tests 
Radiology 
Haemopathology 
Chemical pathology 
Electrocardiography 
 
In the total cost estimate, we included only categories of resource use for which costs 
were highlighted as differing between the two services. Hence drug treatment and referral 
costs were not considered. We excluded common fixed costs, such as overhead costs as 
the two services under study belonged to the same NHS trust. We included an element for 
clinic space. Data on capital and intervention costs were obtained from clinical records 
and savings were calculated for differences identified through the audit. Throughout the 
study service developed so costings are assumed and calculated at the close of the study. 
 
Costing model 
 
We used the costing model shown in figure 8.1 for calculating the resource implications 
of the interventions under real life conditions. In this section, we describe the annual 
intervention costs and service implications. 
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Intervention cost 
per patient 
Total intervention 
cost 
 
    X    = 
Total number  
of patients  
per year       
 
   
 
X       =    
No. Patients 
fluctuating/increasing  
Annual 
intervention  
cost 
Service  
Implications  
 
 
 
Fig 8.1 Annual cost model for memory service resource implication. 
 
Calculation of total annual intervention costs 
 
Patient number assumptions 
 
Calculations were based on information provided by each service about total patient 
numbers. These were estimated at 294 for the MMS and 500 for the MC. 
 
Intervention cost per patient 
 
The annual intervention costs for the MMS and MC Service models were calculated 
assuming fully operational services employing doctors on a sessional basis and nurses on 
an annual basis.  
 
Table 8.2 Annual costs of implementing the MMS service model, investigation costs 
not considered. 
 
 MMS  
Overall service costs: Salary costs:  
0.8 WTE G grade nurse 
 
£19204 
 Full time F grade nurse 
Half time E grade nurse 
Consultant clinic appointment costs 
               
Transport allowance for nurses 
 
Clinic transport costs  
(@£60 per patient visit = 294 visits, assuming ambulance 
transport required for each patient) 
 
Total annual service cost 
 
£20450 
£10328 
£2338.73 
 
£4232 
 
£17640 
 
 
 
£74192.73 
 
The unit cost per patient was therefore calculated as £252.36 for the MMS model. 
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Table 8.3 Annual costs of implementing the MC service model, investigation costs 
not considered. 
 
 
 MC  
Overall service costs: Salary costs not incurred by the memory clinic budget: 
Receptionist  
Secretary 
 
Costs incurred by the memory clinic budget:  
Full time F grade community nurse 
0.8 WTE F grade community nurse 
 
 
£2315.56 
£13927 
 
 
£20450 
£16360 
 0.2 WTE G grade nurse 
Nurse Consultant services 
Consultant clinic appointment costs 
Staff grade Psychiatrist appointment costs 
Preparations for clinic 
3 consulting rooms, resource room and treatment room 
 
Transport allowance for nurses 
 
Clinic transport costs @ £60 per patient visit = 3 x 500 
visits, assuming ambulance transport required for each 
patient) 
 
 
Total annual service cost 
 
£4801 
£7599.80 
£7299.76 
£6768.84 
£1157.52 
£4755.92 
 
£2576 
 
£90000 
 
 
 
 
£161768.84 
 
The unit cost per patient was therefore calculated as £323.54 for the MC model.  
 
The annual intervention costs of both services need to be considered against the impact 
that costs associated with patient numbers, investigations, ambulance costs and staff 
changes would have on each intervention. These are discussed in the next section. 
 
Service cost implications and sensitivity analysis 
 
Many assumptions were included in costing intervention costs and marginal costs, and in 
order to test the robustness of the model, sensitivity analysis was carried out. The areas 
most likely to be subject to variation were evaluated. 
 
Patient numbers 
 
The intervention costs per patient were based on the assumption that each patient was 
routinely adhering to each service model care pathway. There may however, be some 
patients who do not follow the standard protocol. For example, patients may miss 
appointments or attend more clinic appointments than suggested by each service model. 
Patient numbers may change, as the public becomes more aware of the memory services 
and GPs more aware that they can refer direct to these services. Service implications of 
the audit results were considered. Patient costs were calculated identifying a fluctuation 
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or increase in patient numbers by 10%, and investigation rates reported with 95% 
confidence intervals (Drummond & Jefferson 1996). 
 
Table 32 below shows the comparison between the two service models when the patient 
volume is raised or lowered by a 10% margin. 
 
Table 8.4 Service model costs 
 
SERVICE 
MODEL 
Patient numbers Unit cost per case 
MC 550 £294.12 
 450 £359 
MMS 323 £229.70 
 265 £279.97 
 
The MC costs per case are larger than MMS costs when patient numbers increase and 
they are subject to a lesser degree of fluctuation when patient numbers increase.  
 
Investigation costs 
 
Many assumptions were made in calculating costs. Through the audit phase we explored 
the costs of each care pathway individually and in aggregate to identify the variation in 
costing. Some of the categories of investigation comprised only small numbers of events. 
Confidence intervals of proportions were calculated to identify cost implications and to 
enable readers to calculate costs given different populations. 
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Table 8.5 Confidence interval calculations for the MC 
 
1.CT SCANS 
65.7% patients received scan 
= 328.5 cases 
p = 328.5/500 = 0.657, 1-p = 0.3433, n= 500 
0.657 +-1.96 x √0.001024 = 0.657+-1.96x0.03200 = 0.657+-0.0627 
= 0.5943 to 0.7197 = 297 to 360 
 
2. BLOOD TESTS 
77.6% patients received tests 
= 388 cases 
p = 388/500 = 0.776, 1-p = 0.224, n= 500 
0.776 +-1.96 x √0.000790 = 0.776+-1.96x0.028108 = 0.776+-0.05509 
= 0.72091 to 0.831 = 364.5 to 415.5 
 
3. URINALYSIS 
34.3% patients received tests  
= 171.5 cases  
p = 171.5/500 = 0.343, 1-p = 0.657, n= 500 
0.343 +-1.96 x √0.00102432 = 0.343+-1.96x0.032005= 0.657+-0.0627 
= 0.281 to 0.405 = 140.5 to 202.5 
 
4. ECG 
6% patients received test 
= 30 cases 
p = 30/500 = 0.06, 1-p = 0.94, n= 500 
0.06 +-1.96 x √0.0002563 = 0.06+-1.96x0.016011 = 0.06+-0.0313822 
= 0.028618 to 0.091382 = 14 to 46 
 
 
 
Table 8.6 MC investigation costs 
 
 MC investigation costs 
  Cost (£) 
Cost category No of potential episodes  Total  Per case 
 Assumed CI Assumed CI Assumed CI 
CT scan  328.5 297-360 4993.2 4514.4-5472 15.20 15.20 
Urinalysis 171.5 140.5-202.5 154.35 126.45-182.25 0.90 0.90 
Blood tests 388 364.5-415.5 271.6 255.15-290.85 0.70 0.70 
ECG 30 14-46 9 4.2-13.8 0.30 0.30 
Transactions 500 500 3050 3050 6.10 6.10 
Total investigation costs: £8478.15 
Total cost at the upper 95% confidence limit: £7950.2 
Total cost at the lower 95% confidence limit: £9008.9 
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Table 8.7 Confidence interval calculations for the MMS. 
 
1.CT SCANS 
29.9% patients received scan 
= 87.9 cases 
p = 87.9/294 = 0.299, 1-p = 0.701, n= 294 
0.299 +-1.96 x √0.001047995 = 0.299+-1.96x0.032372 = 0.299+- 0.06344912 
= 0.235 to 0.362 = 69 to 106 
 
2. BLOOD TESTS 
87.2% patients received tests 
= 256.4 cases 
p = 256.4/294 = 0.872, 1-p = 0.128, n= 294 
0.872+-1.96 x √0.00055808 = 0.872+-1.96x0.0236237 = 0.872+- 0.046302452 
= 0.82569 to 0.91830 = 243 to 270 
 
3. URINALYSIS 
0% patients received tests 
 
4. ECG 
82.1% patients received test 
= 241.4 cases 
p = 241.4/294 = 0.821, 1-p = 0.179, n= 294 
0.821 +-1.96 x √0.000734 = 0.821+-1.96x0.0271071 = 0.821+- 0.053129916 
= 0.767870084 to 0.874129916 = 226 to 257 
 
Table 8.8 MMS investigation costs 
 
 MMS investigation costs 
  Cost (£) 
Cost category No of potential episodes  Total  Per case 
 Assumed CI Assumed CI Assumed CI 
CT scan  88 69-106 1337.6 1048-1611.2 15.20 15.20 
Urinalysis 0 0 0 0 0.90 0.90 
Blood tests 256 243-270 179.2 170.1-189 0.70 0.70 
ECG 241 226-257 72.3 67.8-77.1 0.30 0.30 
Transactions 294 294 1793.4 1793.4 6.10 6.10 
Total investigation costs: £3382.5 
Total cost at the upper 95% confidence limit:£3079.3 
Total cost at the lower 95% confidence limit:£3670.7 
 
 
More investigation costs were incurred by the Memory Clinic. The audit data suggests 
that patients referred to the MMS service more frequently had already had investigations 
conducted by their GP. Hence, costs to the MMS service were reduced. In consideration 
that not all patients have had all the tests conducted, the unit total investigation cost per 
patient identified through this analysis was calculated as £16.96 for implementing the 
MC model and £11.50 for the MMS. The total unit cost at the upper 95% confidence 
limit was calculated as £18.02 for the MC and £12.48 for the MMS and the total cost at 
the lower 95% confidence limit was £15.90 for the MC and £10.47 for the MMS. 
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Ambulance costs 
 
Ambulances were costed between £40 and £80 pounds a visit. Therefore, the mid point of 
this range at £60 was the assumed cost in calculating the total service costs. Therefore, 
we estimated the costs of the two services adopting the highest and lowest ambulance 
costs given the current patient numbers and staffing configurations. 
 
Table 8.9 Potential service costs implementing varied ambulance transport costs per 
visit 
 
 MMS MC 
Cost per 
ambulance visit 
40 60 80 40 60 80 
Total cost of 
service 
£68312.7
3 
£74192.7
3 
£80072.7
3 
£131768.8
4 
£161768.8
4 
£191768.8
4 
Total cost per 
patient 
£232.36 £252.36 £272.36 £263.54 £323.54 £383.54 
 
Staffing 
 
In consideration of the current staffing of the services and the need for development to 
cater for the expected increase in patient numbers, we estimated the costs of providing 
the same services using different configurations of staffing. 
 
Table 8.10 Potential annual costs of implementing the MMS service 
model, investigation costs not considered 
 
 MMS  
Overall service costs: 1. Salary costs:  
Full time G grade 
2x Full time F grade nurse 
1x Full time E grade nurse 
 
£24005 
£40900 
£18240 
  
Consultant clinic appointment costs 
               
Transport allowance for nurses 
 
Clinic transport costs  
(@£60 per patient visit = 588 visits ) 
Total annual service cost 
 
 
£4677.46 
 
£6992 
 
£35280 
 
£130094.46 
 
 
In significantly increasing the staffing capacity of the MMS and effectively allowing the 
patient case load to be doubled, the annual cost would be £31674.38 less than the current 
cost of operating the MC (£161768.84) with 500 patients. The unit cost would be slightly 
less than the current MMS service model at £221.24 per patient. 
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Table 8.11 Potential annual costs of implementing the MC service model, 
investigation costs not considered  
 
 MC  
Overall service costs: Salary costs not incurred by the memory clinic budget:  
Receptionist 
2 x Secretary 
 
Costs incurred by the memory clinic budget: 
2x Full time F grade community nurse 
 
 
£2315.56 
£27854 
 
 
£40900 
 0.8 WTE F grade community nurse 
2x 0.2 WTE G grade nurse 
Nurse Consultant services 
Consultant clinic appointment costs 
Staff grade Psychiatrist appointment costs 
Preparations for clinic for two days 
3 consulting rooms, resource room and treatment room 
for two days 
 
Transport allowance for nurses 
Clinic transport costs @ £60 per patient visit = (3 x 1000 
visits) 
Clinic transport costs  
 
 
Total annual service cost 
 
£16360 
£9602 
£7599.80 
£7299.76 
£2707.36 
£2315.04 
£9511.84 
 
 
£3434.66 
 
 
£180000 
 
 
£279,730.46 
 
Again we have significantly increased the staffing capacity, with a slightly different but 
workable staffing configuration that would allow the clinic to run over two days and 
serve double the amount of patients at clinic and within the community. This service cost 
if halved would be £139,865.23. This would make an annual net saving of £21,903.46 as 
compared to the current staffing configuration to run the service for one-day 
(£161,768.64). In this case, the unit cost per patient would be reduced to £279.73 (from 
£323.54). 
 
Through these tabulations we can identify the workable staffing ratios to meet future 
patient volumes adopting the MC and MMS service designs. 
 
Implications of the analysis 
 
Decision-makers should appraise the net costs of the services based on point estimates, 
bearing in mind that values toward the centre of a confidence interval are known to be 
likely, and that lower limits of confidence rarely play a practical part in decision-making 
(Briggs & Fenn 1998). 
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9 
Discussion 
 
 
 
 
We discuss the results of the research in relation to the issues identified, the study 
objectives and previous research in the field. We also discuss the methodological 
limitations of the study and implications for practice and service development. 
 
9.1 Stakeholder satisfaction with the two memory services 
 
General issues 
 
All stakeholders were generally satisfied with the performance of both services.  The 
majority of participants were enthusiastic about the effectiveness of the drug treatments. 
Levels of benefit amongst participants varied, from minor benefits in some cases 
(stability/+1 MMSE score) to major improvements (highest recorded a +5 improvement 
in MMSE).  Satisfaction with the service was also affected by these drug benefits and 
treatment waiting times. Waiting times prior to the commencement to this study were 
high but during the course of this study they fell. This was probably a result of 
streamlining the services (e.g. MMS referral practices, appointment of a MC community 
nurse).  However, the ability of the services to further improve waiting times may be 
limited given the increasing volume of referrals; at the completion of this study the MMS 
had 94 more referrals and the MC had 270 more referrals than at the start of the study. By 
stimulating increased demand, these services may become victims of their own success.  
 
9.1.1 The MMS 
 
Patients, carers and professionals involved with or using the MMS recorded high rates of 
satisfaction. The key issues are summarised in the box below: 
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MMS Key Findings 
- The MMS is designed to minimise inconvenience to patients and carers.  
- The MMS nursing staff understands that providing care in the home gives them the 
opportunity to assess dementia patients within their everyday settings. Thus receive a 
more realistic picture of the patient’s condition and needs.  
- The community focus of the service causes patients and their carers to differentiate the 
MMS from traditional surgery/clinic/hospital based services. This removes stigma 
associated with hospital sites previously associated with mental illness.  
- The MMS possessed a high level of integration with the Alzheimer’s Society, which 
assumed the role of information provider, as well as acting as an intermediary between 
patients and health care services.  Carers regularly highlighted this integration as one of 
the major benefits of the service.  
- Information provided was often given verbally during consultations.   
- GP’s noted generally high levels of satisfaction with information provided.   
- Patients and carers reported that issues could be openly discussed with the memory 
nurses. This helped to reduce levels of anxiety experienced by patients and their carers 
relating to the treatment process.  
 
9.1.2 The MC 
 
The MC provided a greater range of diagnostic testing in the form of baseline 
assessments and instruments to determine cognitive and behavioural changes than the 
MMS. The key issues are summarised below: 
 
MC Key Findings 
- The more rigorous testing at the MC was not a major concern amongst patients and their 
carers, who were often ignorant of the role of individual testing.   
- Some carers highlighted concerns regarding the number of tests conducted, and also with 
the system used in the clinic where carers were not present during cognitive testing, which 
contributed to feelings of anxiety in patients.  
- Carers expected some clinic attendance but some felt that a clinic setting was not the best 
place for assessment to take place.  
- Some carers thought that testing the patient in their home environment would provide a 
more accurate picture of their level of dementia. 
- Both the qualitative and quantitative data highlighted more erratic provision of information 
in the MC. Some individuals felt under-supported in their needs for information on 
dementia and support available.  
- Patients and carers felt that little time was available within the MC to allow carers the 
opportunity to discuss issues. 
- The MC was a good potential place for psychosocial support and information to be 
provided to carers, either through an information pack, or through a suitably trained 
individual who could assist during clinic visits.   
- Issues were also apparent relating to communication with and information transfer to 
other agencies.  Lower levels of satisfaction with information provided by the service were 
found amongst GP’s referring patients to the MC. There were also lower levels of 
satisfaction in Wakefield in relation to shared care protocol arrangements.  
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9.2 Clinical audit of patient records for compliance with NICE 
guidance 
 
The analysis of patient records showed that both services exhibited high levels of 
compliance, both with NICE guidance and with local standards based upon the original 
service designs for both the MC and the MMS.   
 
While both services exhibited high levels of compliance with NICE guidance, extensive 
differences were recorded in the range of tests used. As noted, generally the MC conducts 
a more extensive range of cognitive and other tests, reflecting a service design less 
dependent on GPs making preliminary assessments. The MC was research active to a 
higher degree than the MMS, with several projects and trials being conducted in 
conjunction with the clinic (resulting in useful outcomes!), and with a more extensive 
system of computer records used for research and audit purposes.  
 
In contrast the MMS did the minimum assessments needed to comply with NICE 
guidance, reflecting the sole focus of the MMS on delivering treatment in accordance 
with this guidance.  The MC performed more CT scans than the MMS and the MMS 
performed more ECGs than the MC. This probably reflected easier access to CT scans in 
Wakefield and higher concerns about cardiac side effects in Huddersfield.  
 
9.3 The process whereby patients are not selected for 
treatment or treatment discontinued 
 
This phase was abandoned due to recruitment difficulties as detailed earlier in the report. 
 
9.4 Cost analysis 
 
Many assumptions were made in calculating the costs of the two services. However, the 
transparency of the analysis identifies cost implications for both services and given 
different populations. The MMS costs were significantly lower than the MC costs. These 
findings need to be weighed in the balance in combination with all other factors reported 
by this study. Although the MC may have higher costs, more comprehensive assessment 
procedures were conducted by the service and it served as a resource for research as well 
as service delivery. 
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10 
Conclusion 
 
 
 
 
10.1 Comparisons with previous research 
 
Communication and information 
 
The relationship between patient, carers and memory services staff influenced the degree 
to which the service they received was valued. Patients and carers appreciated having 
close relationships with the nurses, rather than distant and professional ones. Indeed, it 
was felt by MMS participants that the patient, carer, nurse relationships provided 
informal therapy. Communication with patients has been recognised previously as one of 
the most important aspects of nursing older people (Armstrong-Esther et al 1989, Van 
Cott 1993). Indeed, research has shown that psychosocial intervention, even at an 
informal level can have significant benefit for patients and carers. A randomized 
controlled trial has shown that psychosocial intervention for spouse care givers can 
improve social support and reduce depression among the care givers, helping prevent or 
postpone a residential/nursing home placement of their spouses with Alzheimer’s 
(Mittelman 2003). Our findings strengthen the case for memory nurses to develop good, 
consistent, person-centred relationships to support patients and caregivers. 
 
Patients and carers identified the need for explanations and opportunities to ask questions 
and clarify treatment not only at diagnosis but also throughout the disease process as the 
condition or treatment changed. There has also been a growing debate on whether 
patients with dementia should be informed of their diagnosis. Until recently, little was 
known about patients themselves. Pinner & Bouman (2003) showed that patients wish to 
be fully informed. Patients and carers wanted to be prepared for what might come next, to 
help them to understand more fully the future challenges and problems they might 
encounter. They also wanted the opportunity to be able to discuss concerns and 
observations. The importance of listening to the ‘voice’ of patients and carers in order to 
appreciate the diversity of their experience has been noted (Laws & Radford, 1998).  
 
All carers felt that they should be provided at the earliest opportunity with more 
information about the range of health and social care provision. There was agreement that 
information given by professionals within both the memory services was often limited 
and / or provided too late. Carers wanted professionals to anticipate their needs and 
instigate early referral to appropriate care agencies or professionals to prevent crisis. 
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Other research has shown that patients and carers tend to rate services positively in terms 
of the information provided to them (Van Hout et al 2001). 
 
The professional participants recognised the importance of providing timely accurate 
information. The services, in accordance with the National Service Framework for Older 
People (Department of Health 2001) provided ample information on the diagnosis of 
dementia, treatments available, side effects of treatment and other health related issues. 
However, they provided little information on coping with dementia, or about other 
services providing financial and other forms of assistance.  Given the nature of dementia, 
with a long term, progressive deterioration in cognitive and emotional states within 
patients, many carers felt that by not providing information and support in this area, a 
vital part of the overall treatment process was being overlooked. The psychosocial 
impacts of the diagnosis on patients must be considered, with appropriate support as a 
central function of memory care services (Vernooij Dassen et al, 2003) 
 
Social support 
 
Most of the patients and carers interviewed viewed the symptoms of dementia as a 
natural part of the ageing process. This, in some cases seemed to delay patients and their 
carers seeking help. The immediate response of denial has previously been shown to 
cause delay in seeking care, although it is eventually recognised that medical intervention 
is needed (Morse 2000). Thus, a focus upon receiving assistance at the early stages of the 
disease process would be beneficial in preparing patients and carers for the future. The 
introduction of drug treatment has brought new hope for patients and their carers. Their 
fears of living with dementia may have developed historically from seeing how persons 
with the condition were stigmatised and institutionalised.  
 
An earlier study of carers of people with Alzheimer’s disease found them to be at greater 
risk for adverse health related outcomes than caregivers of older people with other health 
problems (Ory et al 1999). The dominant paradigm used by social and behavioural 
scientists in family care-giving research is based on the stress and coping model (Lazarus 
1966), developed most creatively in the work of Pearlin and colleagues (Pearlin & 
Schooler 1978, Pearlin et al 1990). In elaborating on the stress process underlying family 
care for relatives with dementia, Pearlin and colleagues (1990) presented a conceptual 
model linking the background and context of stress, the immediate sources of stress, 
mediators of stress (coping and social support), and the outcomes or manifestations of 
stress. In our study, it appeared that participants, regardless of whether they were patients 
or carers, were able to cope better with the condition when they were given diagnosis and 
treatment related information and social support. For these participants, the Alzheimer’s 
society was a highly valued source of information and the memory nurses of 
psychological or social support. 
 
The term ‘social support’ is generally used to refer to the perceived comfort, caring or 
help one individual receives from others and includes esteem support, information 
support, social companionship and instrumental (or practical) support (Ogden 2000). The 
inter-dependent nature of the components of social support is evident in the accounts 
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given by the carers, memory service staff and the Alzheimer’s society representatives. 
For example, carers gain considerable esteem and companionship support from other 
carers of patients with dementing conditions. Carers struggle where inadequate 
information given to them about support groups and when referral is delayed. Carers also 
receive considerable support from professionals with whom they develop trusting 
relationships. Community oriented approaches to the treatment of dementia have 
previously been shown to provide benefits to patients and carers in the realm of 
psychosocial support (Keady & Adams 2001, Woods et al 2003). When insufficient 
instrumental (or practical) support is provided by statutory and voluntary agencies (such 
as respite care) this impacts upon coping. 
 
Whilst the importance of support for carers was identified by professionals, many of the 
concerns professionals rose about service delivery and organisation illustrated the 
inadequate levels of social support currently provided. The accounts provided by 
professionals are reflected in those given by carers who feel socially isolated and 
perceive themselves to be not fully supported by statutory services. In their accounts 
patients and carers described individual styles of coping including denial, long-term 
positive outlook or on day-to-day well being. However, they found maintaining 
emotional equilibrium difficult and at times reported periods of crisis and emotional 
turmoil. Service planners need to acknowledge the potential psychological consequences 
of dementia for patient and carer and provide appropriate support services.  In this study, 
professionals recognised and identified many of the stressors and factors affecting coping 
and adjustment including the need for support during periods of deterioration, the wider 
needs of the carers, inadequate respite and the financial implications for families.  
 
Adjustment 
 
This study demonstrated that adjustment to a diagnosis of dementia is more than just a 
discrete event for both patient and carer. It involved patients and carers going through a 
period of denial and life reorganisation to a period of adjustment and hope. Researchers 
have previously attempted to approach the adjustment phenomenon as if it is ‘linear’ and 
‘static’. There is a lack of thorough understanding of the processes through which older 
people make their day-to-day adjustments before and after a diagnosis of dementia. The 
onset of dementia places major demands on coping resources, and the development of 
adaptive coping strategies, and so the development of adaptive coping strategies is crucial 
in optimising well being and minimising excess disability (Clare 2002).  
 
Understanding how people with early stage dementia differently and naturally attempt to 
adjust and cope is an important starting point in developing interventions that can 
enhance self-efficacy and adaptive coping. It is apparent that a community service is 
easier for patients and carers to adjust to. A major finding in the current study was 
patients and carers dislike for the locality of the hospital appointments, in relation to the 
history of the site and the inconvenience and anxiety associated with attendance. User 
satisfaction is not a simple measure based upon service practices and clinical measures of 
efficacy. The ethnographies of inclusion and exclusion can shape perceptions of health 
and social care services (Parr 2000). In sensitive and stigmatised areas such as mental 
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health, issues relating to the reduction of this stigma as felt by patients and carers should 
be an important element of service design. Recognising how patients and carers cope 
with the diagnosis of Alzheimer’s disease and respond to memory monitoring and 
treatment can only enhance current and future specialised memory services that 
incorporate into their service model facets of care to meet both patient and carer need.  
 
10.2 Methodological limitations 
 
Interpretation of the findings of the study must take account of the limitations of key 
elements of the research design including the sampling design, characteristics of study 
participants and the general assessment of current service provision and needs.  
 
The characteristics of patient and carer participants included in the final sample reflected 
the limitations associated with the sampling design. The sample was wholly Caucasian 
and does not reflect the ethnic diversity of the population studied. The population under 
study includes a relatively high ethnic minority population and so the results of the study 
cannot necessarily be generalised to patients and their families, from ethnic minority 
communities. For the qualitative phases of the research, both patients and carers were 
identified and invited to participate by a link professional for each study centre. They 
acted as gatekeepers to recruitment of participants to prevent any intrusion on the part of 
the researchers and to comply with the Data Protection Act (1998). An important 
limitation resulted from this approach. Where the link professional considered a patient 
invitation to participate inappropriate (for example, due to main language spoken or 
concerns about the potential for distress) then no invitation was made. 
 
Furthermore, the relationships among variables cannot be considered causal because the 
study was cross-sectional. For example, the affective responses reported by patients and 
carers may not have resulted from lack of support but may instead have reflected a pre-
existing condition which influenced self-reports. The cross-sectional design also 
restricted the application of the results, which cannot be used to assess the effects of 
service changes over time. 
 
A number of limitations were evident in the questionnaire phase of the research. One was 
the relatively small sample sizes achieved, in combination with differing response rates 
between patients and carers within the two services.  This discrepancy in response rates 
might have been attributable to a variety of factors, and might also serve to contribute to 
the findings of the questionnaire relating to levels of satisfaction experienced by service 
users and their carers.  Questionnaires were sent to all users currently active within each 
service, based upon data provided by staff within the two memory services.  A variety of 
issues arose from the use of this data.  Many patients who received questionnaires were 
unable to complete them due to their level of cognitive impairment. Questionnaires were 
also sent to patients, rather than to their main carers.  This was unavoidable, as carer 
details are not routinely collected by the services. This may have resulted in difficulties 
where carers were not present.  Carers played important roles as gatekeepers which may 
have impacted upon the final response rate for patient questionnaires.  For example, some 
carers contacted the researchers and clinical staff concerning the distress caused through 
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receiving questionnaires.  This distress was often based upon a perception that treatment 
might be removed depending on the results of the questionnaire.  Although attempts were 
made to reassure carers regarding the issues of confidentiality and anonymity, in many 
cases this was unsuccessful, resulting in a reduced response rate. 
 
In the case of the MC, one problem that may have influenced response rates, related to 
the accuracy of records kept in the clinic as some questionnaires were sent to patients 
who were deceased.  This understandably caused a great deal of distress to relatives who 
received these questionnaires, and clearly would have impacted upon the response rate. 
The research would have benefited from a suitable checking process, such as permission 
to contact the GP prior to attempting contact with an older person who has not recently 
been seen at clinic. 
 
Difficulties in the analysis of questionnaire data were seen as a result of discrepancies 
between the response gained from patients using the MC and MMS. Comparison of 
results using frequency counts became difficult.  As a result all data was expressed as 
percentages to enable intuitive comparisons between the two services. Raw numbers 
were, of course still used for statistical purposes. However, because of the small sample 
size, results may not truly be representative of opinions amongst memory clinic users and 
their carers. 
 
Relating to the questionnaire distributed to GP’s within the Huddersfield and Wakefield 
areas, limitations arose relating to the different sampling techniques. Originally, contact 
details were to be collected from patient and carer questionnaires.  However as a result of 
poor response rates amongst MC service users, alternative methods of recruitment had to 
be used.  As the MMS had provided a list of referring GP’s, a census of all GP’s that 
were currently referring patients was conducted.  However because a similar list could 
not be gained from the MC, alternative sampling methods had to be used.  In the case of 
the MC, questionnaires were sent to the practice managers of all GP practices that were 
identified as being within the MC catchment area.  These different sampling techniques 
may have affected the data that was collected. 
 
In relation to the cost analysis, the limitations of hospital costing information should be 
considered. Although financial estimates have been refined in recent years, there are still 
large disparities between hospitals in their cost estimates for the same procedure. Until 
costing conventions and hospital accounting practice are universal, the generalisability of 
such costing data will be limited. This study, though, identifies models that could be used 
to assess other schemes using locally based costs. 
 
Despite these limitations some research and practice implications may be drawn from the 
research findings. These are discussed within the following sections. 
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10.3 Implications for practice and service development 
 
Research implications 
 
The findings carry implications for research on dementia. Participating in the study, for 
some individuals, conveyed a sense of being ‘useful’ and of having something special to 
offer. A similar observation is reported by Sabat (2001), who engaged a number of 
people with dementia in a collaborative research endeavor aimed at understanding the 
experience of the disease. The philosophy underlying qualitative methodologies such as 
Interpretative Phenomenological Analysis (IPA) often leads to a view of research 
participants as collaborators in the research enterprise (Yardley 2000), and participant 
feedback and comments may be incorporated into the process of data analysis. The 
observation that participating in research could provide a source of self-esteem means it 
would be valuable to explore the further possibility of conducting genuinely collaborative 
research with people who have early stage Alzheimer’s disease and their families. The 
subjective experience of dementia, once neglected by researchers (Cottrell & Schulz 
1993) is now clearly on the agenda. 
 
More memory service evaluation research is required especially because there are no 
current guidelines with regard to how such a service should work. Furthermore, as 
recognised by Keady and Adams (2001), there is a paucity of evaluative work on nursing 
in dementia care. 
 
Practice implications 
 
Although further research is indicated, the findings nevertheless provide a comprehensive 
overview of the two memory services and provide a valuable foundation for developing 
memory services.  
 
The research findings illustrate the inter-dependant nature of relationships, service 
provision, social support and coping. The findings highlight the importance of: 
• Professional inter-personal skills  
• Professional communication skills  
• The provision of information to patients and carers  
• A need to respect patient and carer views  
And  
• To adopt a holistic patient and carer centered approach to service delivery.  
 
Alongside the increasing emphasis on early detection of Alzheimer’s disease, there is a 
growing emphasis on the development of early psychosocial interventions [for example, 
counselling at the time of diagnosis (Husband 1999, 2000), support groups (Yale 1999), 
cognitive rehabilitation (Clare et al 2000, Camp, Bird & Cherry 2000), and the provision 
of advice and support to patients and families (Moniz-Cook et al 1998)]. Such 
interventions need to be underpinned by an understanding of the coping strategies and 
processes that are naturally used by people with dementia. 
 
 77
Memory matters: A report exploring issues around the delivery of anti-dementia medication 
                                                                                                                                                    
 
Service development 
 
The accounts presented here suggest that memory services should be developed to 
incorporate a range of elements that could be selected and adapted according to 
individual needs, including the following: 
 
• A community focus where practicable to reduce anxiety and stigma. 
• A service structure that allows contact with one consistent member of staff and avoids 
professional “distance”. 
• Enhancing social support, and reducing isolation. 
• Providing opportunities to talk about the experience and emotional impact of 
dementia. 
• Helping people identify and engage in activities they still enjoy. 
• Identifying ways of patients being useful and making a contribution 
• Enabling people with dementia and their carers to access information that is 
appropriate to their needs 
 
Specifically, local service planning and development needs to consider: 
 
• The support needs of dementia patients and their carers 
• The role of the wider multi-disciplinary team in the direct support of patients and 
carers or indirect support through education and information support. 
 
Final remarks  
 
One important finding from the current study is the preference most stakeholders held for 
patients being seen in their own homes. This does not deny the highly commendable 
work of clinic based services but may be consideration for future memory services. 
Memory clinics are evolving and existing clinics constantly changing and as the ageing 
population increases and public knowledge of anti-dementia therapies become more 
widespread the demand for memory services will increase (Ellis 2004). In this 
knowledge, it may be impractical in the future to reach the patient population via a 
mainly clinic based service. In developing a memory service to meet the future patient 
increase and preference a more ‘virtual’ community clinic could be designed gathering 
results centrally for research purposes and requiring clinic attendance only if essential for 
diagnosis. The ability of specialist nurses to support GPs in making the diagnosis and 
monitoring treatment could lead to future services being community based with input 
from secondary services to train and enable and to deal with diagnostic and management 
problems. 
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